FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Javier Gisbert

Research Profile

Disorders

Living Beings

Helicobacter pylori

Chemicals & Drugs

Procedures

Concepts & Ideas

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Javier Molina Infante; D A Katzka; Javier P Gisbert
Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis.
Javier P Gisbert; Fernando Gomollón; Angel Lanas; Carlos Martín de Argila; Adrián G McNicholl; Fermín Mearin; Javier Molina Infante; Miguel Montoro; José María Pajares; Angeles Pérez-Aisa; Emilio Pérez-Trallero; F Bermejo; Daniel Boixeda; Felipe Bory; Luis Bujanda; Xavier Calvet; Manuel Castro-Fernández; Enrique Dominguez-Muñoz; Juan Ignasi Elizalde; Montserrat Forné; Emili Gené; Jordi Sánchez-Delgado
[III Spanish Consensus Conference on Helicobacter pylori infection].
Javier Molina Infante; Javier P Gisbert
Letter: seeking oesophageal eosinophilia among unselected patients - looking for a needle in a haystack?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Javier Gisbert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Javier Molina Infante; D A Katzka; Javier P Gisbert
Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis.
Alimentary pharmacology & therapeutics 2013;37(12):1157-64.
2013: Javier P Gisbert; Fernando Gomollón; Angel Lanas; Carlos Martín de Argila; Adrián G McNicholl; Fermín Mearin; Javier Molina Infante; Miguel Montoro; José María Pajares; Angeles Pérez-Aisa; Emilio Pérez-Trallero; F Bermejo; Daniel Boixeda; Felipe Bory; Luis Bujanda; Xavier Calvet; Manuel Castro-Fernández; Enrique Dominguez-Muñoz; Juan Ignasi Elizalde; Montserrat Forné; Emili Gené; Jordi Sánchez-Delgado
[III Spanish Consensus Conference on Helicobacter pylori infection].
Gastroenterología y hepatología 2013;36(5):340-74.
2013: Javier Molina Infante; Javier P Gisbert
Letter: seeking oesophageal eosinophilia among unselected patients - looking for a needle in a haystack?
Alimentary pharmacology & therapeutics 2013;37(10):1029-30.
2013: M Chaparro; Javier P Gisbert
Letter: dry blood spots for anti-TNF treatment monitoring in IBD - authors' reply.
Alimentary pharmacology & therapeutics 2013;37(10):1025-6.
2013: Alicia C Marin; Adrian G McNicholl; Javier P Gisbert
A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).
Expert opinion on pharmacotherapy 2013;14(7):843-61.
2013: Javier Molina Infante; Javier P Gisbert
Quadruple therapy for Helicobacter pylori infection.
Lancet 2013;381(9876):1459.
2013: Javier P Gisbert; María Chaparro
Vaccination strategies in patients with IBD.
Nature reviews. Gastroenterology & hepatology 2013;10(5):277-85.
2013: William Zabala; Montserrat Andreu; Manuel Barreiro-de Acosta; Francisco Barros; Daniel Carpio; Angel Carracedo; María Chaparro; Raquel Cruz; Eugeni Domenech; Ana Echarri; Maria Esteve; Esther García-Planella; Javier P Gisbert; Julián Panes
New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients.
Pharmacogenomics 2013;14(6):631-40.
2013: María Chaparro; Javier P Gisbert
Response to Tung et al.
The American journal of gastroenterology 2013;108(4):621-2.
2013: Fernando Fernández-Bañares; Maria Esteve; Javier P Gisbert
Letter: mucosal healing and mortality in coeliac disease.
Alimentary pharmacology & therapeutics 2013;37(7):760-1.
2013: José Luis Cabriada; Eugeni Domènech; María Esteve; Javier P Gisbert; Fernando Gomollón; Julia Panés; Isabel Vera; Manuel Barreiro-de Acosta
[Recommendations of the Spanish Working Group on Crohn's disease and ulcerative colitis on the use of anti-tumor necrosis factor drugs in inflammatory bowel disease].
Gastroenterología y hepatología 2013;36(3):127-46.
2013: Javier P Gisbert; Amelia Rodríguez-Nogueiras; Jose Ramón Villagrasa; María Chaparro
Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease.
Inflammatory bowel diseases 2013;19(3):554-8.
2013: M J Casanova; M Chaparro; Eugeni Domènech; C Dueñas; Maria Esteve; S García-López; Esther García-Planella; V García-Sánchez; E Garrido; Daniel Ginard; María Gómez-García; Fernando Gomollón; E Iglesias; M López; Míriam Mañosa; José Maté; J L Pérez-Calle; Mireia G Piqueras; Angel Ponferrada; Luis Rodrigo; C Saro; carlos taxonera; Manuel Barreiro-de Acosta; B Beltrán; F Bermejo; B Botella; Xavier Calvet; M Calvo; Javier P Gisbert
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease.
The American journal of gastroenterology 2013;108(3):433-40.
2013: Fernando Gomollón; Javier P Gisbert
Intravenous iron in inflammatory bowel diseases.
Current opinion in gastroenterology 2013;29(2):201-7.
2013: María Chaparro; Mercedes Guijarro; Consuelo López; Ricardo Moreno-Otero; María Trapero-Marugán; Javier P Gisbert
Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
Journal of Crohn's & colitis 2013;7(2):e61-5.
2013: Fernando Fernández-Bañares; Esther García-Planella; Javier P Gisbert; Eva Iglesias; Beatriz Lobo; Miguel Montoro; Ingrid Ordás; Mireia G Piqueras; Valentí Puig-Diví; Antonio Salas; Josep Maria Viver; Montserrat Andreu; Belén Beltrán; Marta Calvo; Monia R de Sousa; Maria Esteve
Epidemiological risk factors in microscopic colitis: a prospective case-control study.
Inflammatory bowel diseases 2013;19(2):411-7.
2013: Fernando Gomollón; Santiago García-López; Javier P Gisbert; Beatriz Sicilia; Joaquín Hinojosa
Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU.
Gastroenterología y hepatología 2013;36(2):104-14.
2013: Ricardo Moreno-Borque; Javier P Gisbert; Cecilio Santander
Pathophysiological bases of eosinophilic esophagitis therapy.
Inflammation & allergy drug targets 2013;12(1):46-53.
2013: Paula Marticorena-Álvarez; Andrés Pérez-Casas; Maria Chaparro; Javier P Gisbert
Reply to Dr. Katsanos et al.'s letter.
Journal of Crohn's & colitis 2013;7(1):e23-4.
2013: Javier P Gisbert; Iván Guerra; Sam Khorrami; Eloisa Lamas; Inés Modolell; Jesús Ortuño; Angeles Pérez-Aisa; Julio Ponce; Luis Rodrigo; Pilar Sánchez-Pobre; Albert Tomas; Pedro Almela; José Barrio; Fernando Bermejo; Felipe Bory; Xavier Calvet; Manuel Castro-Fernández; Angel Cosme; Miguel Fernández-Bermejo; A Franco
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
Journal of clinical gastroenterology 2013;47(2):130-5.
2013: Javier P Gisbert; Xavier Calvet
Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive Review.
Clinical and translational gastroenterology 2013;4():e32.
2013: Iván Guerra; Javier P Gisbert
Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agents.
Expert review of gastroenterology & hepatology 2013;7(1):41-8.
2013: M Chaparro; Javier P Gisbert
Letter: measurement of anti-TNF-α levels and antibodies against the drug.
Alimentary pharmacology & therapeutics 2013;37(1):163-4.
2013: Eugeni Domènech; Javier P Gisbert
Letter: should colectomy be the end-point to evaluate the effectiveness of drug therapies in severe ulcerative colitis?
Alimentary pharmacology & therapeutics 2013;37(1):160-1.
2013: David Y Graham; Javier P Gisbert
Helicobacter pylori: tailored therapy with novel sequential quadruple therapies.
Nature reviews. Gastroenterology & hepatology 2013;10(1):6-8.
2012: Javier P Gisbert; Pablo Alonso-Coello; Xavier Calvet; Juan Ferrándiz; Juan José Mascort; Mercè Marzo
[Clinical practice guideline on the management of patients with dyspepsia. Update 2012].
Gastroenterología y hepatología 2012;35(10):725.e1-38.
2012: Javier P Gisbert; Pablo Alonso-Coello; Xavier Calvet Calvo; Juan Ferrándiz Santos; Juan José Mascort Roca; Mercè Marzo Castillejo
[Managing of the patient with dyspepsia. Clinical Practice Guideline. Update 2012].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 2012;44(12):728-33.
2012: Javier P Gisbert; Pablo Alonso-Coello; Xavier Calvet; Juan Ferrándiz; Juan Mascort; Mercè Marzo
[Clinical practice guideline on the management of patients with dyspepsia. Update 2012].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 2012;44(12):727.e1-727.e38.
2012: M J Casanova; M Chaparro; S Martínez; I Vicuña; Javier P Gisbert
Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease.
Journal of Crohn's & colitis 2012;6(10):1034-7.
2012: Javier P Gisbert
Drugs and the upper and lower gastrointestinal tract: from inflammation to malignancy.
Current drug metabolism 2012;13(9):1266.
2012: Teresa Cabaleiro; Javier P Gisbert; Manuel Roman; Francisco Abad-Santos
Utility of assessing thiopurine S-methyltransferase polymorphisms before azathioprine therapy.
Current drug metabolism 2012;13(9):1277-93.
2012: Dolores Serrano; Susana Torrado; S Torrado-Santiago; Javier P Gisbert
The influence of CYP2C19 genetic polymorphism on the pharmacokinetics/- pharmacodynamics of proton pump inhibitor-containing Helicobacter pylori treatments.
Current drug metabolism 2012;13(9):1303-12.
2012: Luis G Guijarro; Ma Dolores Fernández-Moreno; Javier P Gisbert; Irene D Román; Borja Hernández-Breijo
Is the autophagy induced by thiopurines beneficial or deleterious?
Current drug metabolism 2012;13(9):1267-76.
2012: Lior Katz; Peter Laszlo Lakatos; Bret Lashner; Kirk Lin; Beth Manoogian; Gerassimos J Mantzaris; Torben Nathan; Yulia Ron; Somal Shah; Casper Steenholdt; Mads Naundrup Svendsen; Arun Swaminath; Jonathan P Terdiman; Epameinondas V Tsianos; C Janneke van der Woude; Laura Yun; Jorn Brynskov; Maria Chaparro; Iris Dotan; Pierre Ellul; Javier P Gisbert; Ailsa Hart; Peter Higgins; Eran Israeli; Konstantinos H Katsanos; Maria Abreu; Ashish Atreja; Shomron Ben-Horin
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response.
Inflammatory bowel diseases 2012;18(11):2026-33.
2012: María Chaparro; Eugeni Domènech; María Esteve; Esther García-Planella; Olga Merino; Pilar Nos; Mireia Peñalva; Elena Ricart; Montserrat Andreu; Manuel Barreiro-de Acosta; Javier P Gisbert
Effectiveness of infliximab after adalimumab failure in Crohn's disease.
World journal of gastroenterology : WJG 2012;18(37):5219-24.
2012: Javier P Gisbert; A Rodríguez-Nogueiras; J R Villagrasa; M Chaparro
Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease.
The American journal of gastroenterology 2012;107(10):1460-6.
2012: Eugeni Domènech; Javier P Gisbert
Letter: real-life management of new onset ulcerative colitis and proctitis.
Alimentary pharmacology & therapeutics 2012;36(7):685-6; author reply 686.
2012: Paula Marticorena-Álvarez; Aurora Muriel-Herrero; Andrés Pérez-Casas; María Chaparro; Javier P Gisbert
Probable diffuse retinopathy caused by adalimumab in a patient with Crohn's disease.
Journal of Crohn's & colitis 2012;6(9):950-3.
2012: Javier P Gisbert
[Helicobacter pylori-related diseases].
Gastroenterología y hepatología 2012;35 Suppl 1():12-25.
2012: J Enrique Domínguez-Muñoz; Javier P Gisbert
[Presenting the latest novelties in gastroenterology].
Gastroenterología y hepatología 2012;35 Suppl 1():1-2.
2012: Bojan Tepes; Javier P Gisbert; Anthony O'Connor; Colm O'Morain
Treatment of Helicobacter pylori infection 2012.
Helicobacter 2012;17 Suppl 1():36-42.
2012: Fernando Fernández-Bañares; Javier P Gisbert
Letter: are lymphocytic colitis and collagenous colitis really the same disease?
Alimentary pharmacology & therapeutics 2012;36(6):606.
2012: Xavier Calvet; Javier P Gisbert
Letter: are idiopathic (non-NSAID, non-Helicobacter pylori) ulcers really increasing?
Alimentary pharmacology & therapeutics 2012;36(6):600-1; author reply 601-2.
2012: A Lopez-Sanroman; Javier P Gisbert
Letter: infliximab and adalimumab in the management of Crohn's disease--are they really comparable?
Alimentary pharmacology & therapeutics 2012;36(5):498-9.
2012: I Guerra; Javier P Gisbert
Letter: anti-TNFs and psoriasis--friends or foes?
Alimentary pharmacology & therapeutics 2012;36(5):497; author reply 498.
2012: A G McNicholl; O P Nyssen; Xavier Calvet; P M Linares; Javier P Gisbert
Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection.
Alimentary pharmacology & therapeutics 2012;36(5):414-25.
2012: Yago González Lama; Pilar López; Antonio López-Sanromán; José Maté; Adrian G McNicholl; Jorge Mendoza; Juan Luis Mendoza; Verónica Opio; Ramón Pajares; José Lázaro Pérez-Calle; carlos taxonera; Alicia Algaba; Almudena Barbero; Fernando Bermejo; Jesús Estelles; Javier P Gisbert
Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience.
European journal of gastroenterology & hepatology 2012;24(9):1086-91.
2012: A G McNicholl; Javier P Gisbert
Commentary: comparators in H. pylori eradication--stating the ethics of statins.
Alimentary pharmacology & therapeutics 2012;36(4):400-1.
2012: Javier Molina Infante; Carmen Pazos-Pacheco; Belen Perez-Gallardo; Gema Vinagre-Rodriguez; Carmen Dueñas-Sadornil; Miguel Fernandez-Bermejo; Guadalupe Gonzalez-Garcia; Moisés Hernandez-Alonso; Jose M Mateos-Rodriguez; Javier P Gisbert
Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Helicobacter 2012;17(4):269-76.
2012: Manuel Barreiro-de Acosta; Javier P Gisbert
Letter: surgery for ulcerative colitis mostly follows anti-TNF drugs--a new 'therapeutic package'?
Alimentary pharmacology & therapeutics 2012;36(3):297-8; author reply 298-9.
2012: Fernando Bermejo; María Chaparro; Alicia Algaba; Esther García-Planella; Elena Garrido; Javier P Gisbert; Jordi Gordillo; Iván Guerra; Antonio López-Sanromán; Míriam Mañosa; Eugeni Domènech
Efficacy of different therapeutic options for spontaneous abdominal abscesses in Crohn's disease: are antibiotics enough?
Inflammatory bowel diseases 2012;18(8):1509-14.
2012: Javier P Gisbert; Miguel Montoro; A Pérez-Aisa; Josep M Piqué; Santos Santolaria; Pedro Almela; R Aznárez; Adolfo Benages; Fernando Borda; Felipe Bory; Xavier Calvet; N Cañete; Manuel Castro; Angel Cosme; N Fernández; Faust Feu; Rafael García-Grávalos
Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding.
The American journal of gastroenterology 2012;107(8):1197-204.
2012: Angeles Pérez Aisa; Enrique Pérez Cuadrado; Francisco Pérez Roldan; Marta Ponce Romero; Luis Rodrigo Saez; Eloy Sánchez Hernández; Angel Sierra Hernández; Anibal Alejandro López Morante; Carlos Martin de Argila; Miguel Montoro Huguet; Maria Muñoz; Javier Nuevo; José María Palazón Azorín; David Aviñoa Arreal; Fernando Borda Celaya; Xavier Calvet; Manuel Castro-Fernández; M Vega Catalina Rodriguez; Enrique Dominguez Muñoz; Faust Feu; Sonia Gallego Montañés; Javier P Gisbert; Angel González Galilea; Yanira González Méndez; José Manuel Gonzalvo Sorribes; Angel Lanas
[Current management of nonvariceal upper gastrointestinal bleeding in Spain].
Gastroenterología y hepatología 2012;35(7):468-75.
2012: J Sánchez-Delgado; S Torra; M Barenys; Felipe Bory; L Bujanda; M M Calvo; Manuel Castro-Fernández; P García-Iglesias; Javier P Gisbert; J Lisozain; Xavier Calvet
High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates.
Alimentary pharmacology & therapeutics 2012;36(2):190-6.
2012: Benito Velayos; Lourdes Del Olmo; María F Muñoz; Fernando Pons-Renedo; Lourdes Ruíz; Rocío Aller; Ana Almaraz; L Fernández-Salazar; Javier P Gisbert; José M González-Hernández
Accuracy of urea breath test performed immediately after emergency endoscopy in peptic ulcer bleeding.
Digestive diseases and sciences 2012;57(7):1880-6.
2012: Javier P Gisbert
Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection.
Alimentary pharmacology & therapeutics 2012;35(12):1484-5; author reply 1486.
2012: Javier P Gisbert; I Marín; Luis Menchén; J R Villagrasa; V García-Sánchez; M Chaparro
Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease.
Alimentary pharmacology & therapeutics 2012;35(12):1379-85.
2012: Iván Guerra; Antonio López-Sanromán; Pilar López Serrano; Noemí Manceñido; Ignacio Marín-Jiménez; Pilar Martínez-Montiel; José Lázaro Pérez-Calle; Elvira Quintanilla; Alberto Romero-Maté; carlos taxonera; Mónica Villafruela; María Chaparro; Raquel García-Castellanos; Javier P Gisbert; Yago González Lama; Alicia Algaba; F Bermejo
Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases.
Journal of Crohn's & colitis 2012;6(5):518-23.
2012: Peter Malfertheiner; Francis Megraud; Colm A O'Morain; Theodore Rokkas; John Atherton; Anthony T R Axon; Franco Bazzoli; Emad M El-Omar; Gian Franco Gensini; Javier P Gisbert; David Y Graham; Ernst J Kuipers
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.
Gut 2012;61(5):646-64.
2012: Manuel Román; Teresa Cabaleiro; María Chaparro; Javier P Gisbert; Jesús Novalbos; Dolores Ochoa; Francisco Abad-Santos
Validation of a genotyping method for analysis of TPMT polymorphisms.
Clinical therapeutics 2012;34(4):878-84.
2012: Javier P Gisbert; Adrian G McNicholl
Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital.
Helicobacter 2012;17(2):160-1.
2012: Javier P Gisbert
Letter: the ethics of using inferior regimens in H. pylori randomised trials - invited comment.
Alimentary pharmacology & therapeutics 2012;35(7):856-7; discussion 858.
2012: Javier P Gisbert; E Lamas; E Marcos; I Modolell; Javier Molina Infante; A Perez-Aisa; Luis Rodrigo; J L Cabriada; M Castro-Fernandez; Angel Cosme; Jose Luis Gisbert; Xavier Calvet
Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.
Alimentary pharmacology & therapeutics 2012;35(8):941-7.
2012: M Chaparro; Eugeni Domènech; Maria Esteve; V García; Esther García-Planella; X Aldeguer; M Andreu; M Barreiro-de; J Barrio; J L Cabriada; A Gutiérrez; J Hinojosa; Juan L Mendoza; O Merino; M A Montoro; F Muñoz; Pilar Nos; Julián Panés; M Peñalva; C Saro; I Vera; Pere Vilar; Javier P Gisbert
Long-term durability of response to adalimumab in Crohn's disease.
Inflammatory bowel diseases 2012;18(4):685-90.
2012: A Algaba; F Bermejo; B Casis; P Martínez-Montiel; José Maté; J L Pérez-Calle; A López-San Román; M Van Domselaar; Javier P Gisbert
Intensification of infliximab therapy in Crohn's disease: efficacy and safety.
Journal of Crohn's & colitis 2012;6(1):62-7.
2012: Javier P Gisbert
Rescue Therapy for Helicobacter pylori Infection 2012.
Gastroenterology research and practice 2012;2012():974594.
2012: Javier P Gisbert; Xavier Calvet
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.
Clinical and experimental gastroenterology 2012;5():23-34.
2012: M Chaparro; Esther García-Planella; M Barreiro-de Acosta; Guillermo Bastida; P Burgueño; Xavier Calvet; L Castro; M Gómez; Fernando Gomollón; V Hernández; J Hinojosa; E Iglesias; C Jiménez; Míriam Mañosa; J L Mendoza; F Muñoz; O Pérez Nyssen; Julián Panés; S Gómez Senent; Javier P Gisbert
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
Alimentary pharmacology & therapeutics 2012;35(2):275-83.
2011: Javier P Gisbert; Xavier Calvet
Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
Alimentary pharmacology & therapeutics 2011;34(11-12):1255-68.
2011: Almudena Barbero-Villares; Esteban Daudén; Javier P Gisbert; Isidoro Gonzalez-Alvaro; Jorge Mendoza; María Trapero-Marugán; Ricardo Moreno-Otero
Evaluation of liver fibrosis by transient elastography in methotrexate treated patients.
Medicina clínica 2011;137(14):637-9.
2011: Javier P Gisbert; Xavier Calvet
Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.
Alimentary pharmacology & therapeutics 2011;34(9):1047-62.
2011: Javier Molina Infante; Javier P Gisbert
Levofloxacin in first-line eradication regimens for Helicobacter pylori: better test antibiotic susceptibility before treating.
Gut 2011;60(11):1605; author reply 1605-6.
2011: Javier P Gisbert
[Helicobacter pylori-related diseases: dyspepsia, ulcers and gastric cancer].
Gastroenterología y hepatología 2011;34 Suppl 2():15-26.
2011: J Enrique Domínguez-Muñoz; Javier P Gisbert
[Recent developments presented in gastroenterology].
Gastroenterología y hepatología 2011;34 Suppl 2():1-2.
2011: Xavier Calvet; Javier P Gisbert; David Suarez
Key points for designing and reporting Helicobacter pylori therapeutic trials: a personal view.
Helicobacter 2011;16(5):346-55.
2011: P García-Iglesias; Javier P Gisbert; D Suarez; Albert Villoria; A Barkun; Enric Brullet; F Feu; M Gallach; Xavier Calvet
Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer.
Alimentary pharmacology & therapeutics 2011;34(8):888-900.
2011: Borja Hernández-Breijo; Jorge Monserrat; Sara Ramírez-Rubio; Irene D Román; Diana Vara; Eva P Cuevas; Inés Díaz-Laviada; María Dolores Fernández-Moreno; Javier P Gisbert; Luis G Guijarro
Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma.
World journal of gastroenterology : WJG 2011;17(34):3899-911.
2011: Anthony O'Connor; Javier P Gisbert; D McNamara; Colm O'Morain
Treatment of Helicobacter pylori infection 2011.
Helicobacter 2011;16 Suppl 1():53-8.
2011: Fernando Gomollón; Javier P Gisbert
IBD: Intravenous iron in IBD--what's the best preparation?
Nature reviews. Gastroenterology & hepatology 2011;8(9):477-8.
2011: Javier P Gisbert; Xavier Calvet
Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.
Alimentary pharmacology & therapeutics 2011;34(6):604-17.
2011: Yago González Lama; A López-Sanromán; N Manceñido; José Maté; A G McNicholl; O Merino; C Muñoz; R Pajares; E Ricart; M Velasco; Maria Isabel Vera; Luis E Abreu; A Algaba; LM Benito; F Bermejo; L Bujanda; J L Cabriada; M Calvo; M Calvo; Carlos Cara; JA Carneros; D Carpio; F Casellas; M Esteve; C Froilan; F J García-Fernández; V García-Sánchez; Daniel Ginard; Javier P Gisbert
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients.
Alimentary pharmacology & therapeutics 2011;34(5):544-54.
2011: Leticia Martín Martín; Cecilio Santander; Carlos Chavarría-Herbozo; Jorge Espinoza-Ríos; Javier P Gisbert; Mari Carmen Lopez Martín; Ricardo Moreno-Otero
Esophageal motor abnormalities in eosinophilic esophagitis identified by high-resolution manometry.
Journal of gastroenterology and hepatology 2011;26(9):1447-50.
2011: Javier P Gisbert; María Chaparro; Fernando Gomollón
Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.
World journal of gastroenterology : WJG 2011;17(30):3467-78.
2011: Laura Espinosa; Alicia Bejerano; Pablo M Linares; Cristina Lopez; Ricardo Moreno-Otero; Argeme Sanchez; Javier P Gisbert
Soluble angiogenic factors in patients with acute pancreatitis.
Journal of clinical gastroenterology 2011;45(7):630-7.
2011: Pablo M Linares; Javier P Gisbert
Role of growth factors in the development of lymphangiogenesis driven by inflammatory bowel disease: a review.
Inflammatory bowel diseases 2011;17(8):1814-21.
2011: José Ignacio Fortea-Ormaechea; Javier P Gisbert; Yago González Lama; Luis E Abreu; F Bermejo; B Casis; María Chaparro; Luis Menchén; Ramón Pajares; José Luis Pérez-Calle; Angel Ponferrada; Manuel Van Domselaar; Maria Isabel Vera; Pilar Martínez Montiel; Antonio López-San Román; Pilar López Serrano; Ignacio Marín-Jiménez
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience.
Gastroenterología y hepatología 2011;34(7):443-8.
2011: Iván Guerra; Fernando Bermejo; María Chaparro; Javier P Gisbert
Utility of measuring serum concentrations of anti-TNF agents and anti-drug antibodies in inflammatory bowel disease.
Current drug metabolism 2011;12(6):594-8.
2011: Jesús Legido; Javier P Gisbert; José Maté
[Bone metabolism changes in 100 patients with inflammatory bowel disease].
Gastroenterología y hepatología 2011;34(6):379-84.
2011: Javier P Gisbert
Helicobacter pylori eradication: A new, single-capsule bismuth-containing quadruple therapy.
Nature reviews. Gastroenterology & hepatology 2011;8(6):307-9.
2011: Cristina López-Martín; José Maté; Alicia Bejerano; María Chaparro; Laura Espinosa; Javier P Gisbert
Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease.
Gastroenterología y hepatología 2011;34(6):385-92.
2011: Norman Nuñez-Andrade; Amalia Lamana; David Sancho; Javier P Gisbert; Roberto Gonzalez-Amaro; Francisco Sanchez-Madrid; Ana Urzainqui
P-selectin glycoprotein ligand-1 modulates immune inflammatory responses in the enteric lamina propria.
The Journal of pathology 2011;224(2):212-21.
2011: María Chaparro; Javier P Gisbert
Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease.
Current pharmaceutical biotechnology 2011;12(5):765-73.
2011: Javier P Gisbert
[Ten major publications in 2010 with implications for clinical practice in gastroenterology].
Gastroenterología y hepatología 2011;34(4):289-304.
2011: Javier P Gisbert; M Chaparro; Maria Esteve
Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.
Alimentary pharmacology & therapeutics 2011;33(6):619-33.
2011: Jordi Sánchez-Delgado; Emili Gené; David Suárez; Pilar García-Iglesias; Enric Brullet; Marta Gallach; Faust Feu; Javier P Gisbert; Xavier Calvet
Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression.
The American journal of gastroenterology 2011;106(3):398-405.
2011: Inés D Pousa; Alicia Algaba; Pablo M Linares; Paloma Sanz-Cameno; José Maté; Ricardo Moreno-Otero; F Bermejo; Javier P Gisbert
Corticosteroids modulate angiogenic soluble factors in ulcerative colitis patients.
Digestive diseases and sciences 2011;56(3):871-9.
2011: Maria Chaparro; Javier P Gisbert
Successful use of infliximab for perianal Crohn's disease in pregnancy.
Inflammatory bowel diseases 2011;17(3):868-9.
2011: Javier P Gisbert
[Rescue therapy after Helicobacter pylori eradication failure].
Gastroenterología y hepatología 2011;34(2):89-99.
2011: María Chaparro; Julián Panes; Valle García; Miriam Mañosa; María Esteve; Olga Merino; Montserrat Andreu; Ana Gutierrez; Fernando Gomollón; José Luis Cabriada; Miguel Angel Montoro; Juan Luis Mendoza; Pilar Nos; Javier P Gisbert
Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.
Journal of clinical gastroenterology 2011;45(2):113-8.
2011: Javier P Gisbert
Is culture necessary before first-line treatment for Helicobacter pylori infection?
Internal medicine (Tokyo, Japan) 2011;50(21):2717; author reply 2719-20.
2011: Cristina López-Martín; Enrique de la Fuente-Fernández; Paloma Corbatón; María Chaparro Sánchez; Javier P Gisbert
[Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
Gastroenterología y hepatología 2011;34(1):16-9.
2010: C Santander; Javier P Gisbert; Ricardo Moreno-Otero; A G McNicholl; José Maté
Usefulness of manometry to select patients with anal fissure for controlled anal dilatation.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2010;102(12):691-7.
2010: Angel Lanas; Xavier Calvet; Faust Feu; Julio Ponce; Javier P Gisbert; Alan Barkun
[First Spanish consensus on peptic ulcer bleeding management. Consenso sobre Hemorragia Digestiva por Úlcera Péptica].
Medicina clínica 2010;135(13):608-16.
2010: Javier P Gisbert; Fernando Gomollón; J Hinojosa; A López San Román
Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: a real-life survey in Spain.
Journal of Crohn's & colitis 2010;4(5):567-74.
2010: Gregorio González-Alcaide; José Manuel Ramos Rincón; Javier P Gisbert
[Scientific collaboration and research areas in Gastroenterología y Hepatología and Revista Española de Enfermedades Digestivas (2000-2009)].
Gastroenterología y hepatología 2010;33(9):670-80.
2010: Javier P Gisbert; José María Pajares
Treatment of Helicobacter pylori infection: the past and the future.
European journal of internal medicine 2010;21(5):357-9.
2010: Anthony O'Connor; Javier P Gisbert; D McNamara; Colm O'Morain
Treatment of Helicobacter pylori infection 2010.
Helicobacter 2010;15 Suppl 1():46-52.
2010: María Chaparro; Almudena Barbero; Leticia Martín; Carlos Esteban; Laura Espinosa; Felipe de la Morena; Argeme Sánchez; Irene Martín; Cecilio Santander; Ricardo Moreno-Otero; Javier P Gisbert
Prospective evaluation of a clinical guideline recommending early patients discharge in bleeding peptic ulcer.
Journal of gastroenterology and hepatology 2010;25(9):1525-9.
2010: Carlos Teruel; Antonio López-San Román; F Bermejo; carlos taxonera; José Lázaro Pérez-Calle; Javier P Gisbert; María Martín-Arranz; Angel Ponferrada; Manuel Van Domselaar; Alicia Algaba; Jesús Estellés; Pilar López Serrano; Pablo M Linares; Alfonso Muriel
Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines.
The American journal of gastroenterology 2010;105(9):2003-8.
2010: Mónica Tafalla; Javier Nuevo; Javier Zapardiel; Javier P Gisbert
[Study of the clinical profile and management of patients with gastroesophageal reflux disease in primary care in Spain].
Gastroenterología y hepatología 2010;33(7):490-7.
2010: Valle García-Sánchez; Eva Iglesias-Flores; Raúl González; Javier P Gisbert; José María Gallardo-Valverde; Angel González Galilea; Antonio Naranjo-Rodríguez; Juan F de Dios-Vega; Jordi Muntané; Federico Gómez-Camacho
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
Journal of Crohn's & colitis 2010;4(2):144-52.
2010: Fernando Bermejo; Javier P Gisbert
Usefulness of salicylate and thiopurine coprescription in steroid-dependent ulcerative colitis and withdrawal strategies.
Therapeutic advances in chronic disease 2010;1(3):107-14.
2010: Valle García-Sánchez; Raúl González; Eva Iglesias-Flores; Javier P Gisbert; Jose Manuel Angel-Rey; Pilar Soto-Escribano; Carmen Gálvez-Calderón; Antonio Reyes-López; Francisco Perez-Jimenez; Juan F de Dios-Vega; Jordi Muntané; Federico Gómez-Camacho
Can systemic cytokines predict relapse of inflammatory bowel disease?
Hepato-gastroenterology 2010;57(99-100):524-30.
2010: Maria-Encarnación Fernández-Contreras; José Javier Sánchez-Hernández; Mercedes Guijarro; Javier P Gisbert; Noa Rivas; María-Luisa García de Paredes; Adolfo Hinojar-Gutiérrez; Carlos Gamallo
Influence of thymidylate synthase DNA polymorphisms and gender on the clinical evolution of patients with advanced colorectal cancer.
Oncology reports 2010;23(5):1393-400.
2010: Julián Panés; Javier P Gisbert
Optimizing care of hereditary hemorrhagic telangiectasia.
Gastroenterology 2010;138(5):2014-6.
2010: Javier Molina Infante; B Perez-Gallardo; M Fernandez-Bermejo; M Hernandez-Alonso; G Vinagre; C Dueñas; J M Mateos-Rodriguez; G Gonzalez-Garcia; E G Abadia; Javier P Gisbert
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 2010;31(10):1077-84.
2010: Javier P Gisbert
Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding.
Inflammatory bowel diseases 2010;16(5):881-95.
2010: Javier P Gisbert; Xavier Calvet; J P Anthony O'Connor; Francis Mégraud; Colm A O'Morain
The sequential therapy regimen for Helicobacter pylori eradication.
Expert opinion on pharmacotherapy 2010;11(6):905-18.
2010: Javier P Gisbert; A Pérez-Aisa; M Castro-Fernández; J Barrio; Luis Rodrigo; A Cosme; Jose Luis Gisbert; Santiago Marcos; R Moreno-Otero
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2010;42(4):287-90.
2010: Fernando Gomollón; Javier P Gisbert; José Antonio Garcia-Erce
Intravenous iron in digestive diseases: a clinical (re)view.
Therapeutic advances in chronic disease 2010;1(2):67-75.
2010: F Bermejo; A López-Sanromán; A Algaba; M Van-Domselaar; Javier P Gisbert; S García-Garzón; E Garrido; B Piqueras; G De La Poza; I Guerra
Mercaptopurine rescue after azathioprine-induced liver injury in inflammatory bowel disease.
Alimentary pharmacology & therapeutics 2010;31(1):120-4.
2010: Fernando Gomollón; Javier P Gisbert
[Must immunomodulators be added to biological treatment in inflammatory bowel disease?].
Gastroenterología y hepatología 2010;33(1):43-53.
2009: Javier P Gisbert
Second-line rescue therapy of helicobacter pylori infection.
Therapeutic advances in gastroenterology 2009;2(6):331-56.
2009: Javier P Gisbert; Alun Cooper; Dimitrios Karagiannis; Jan Hatlebakk; Lars Agréus; Helmut Jablonowski; Monica Tafalla
Consultation rates and characteristics of gastro-oesophageal reflux disease in primary care: a European observational study.
The European journal of general practice 2009;15(3):154-60.
2009: Javier P Gisbert; Alun Cooper; Dimitrios Karagiannis; Jan Hatlebakk; Lars Agréus; Helmut Jablonowski; Monica Tafalla
Management of gastro-oesophageal reflux disease in primary care: a European observational study.
Current medical research and opinion 2009;25(11):2777-84.
2009: Felipe de la Morena López; Javier P Gisbert
[Prevalence and characteristics of anemia in inflammatory bowel disease].
Gastroenterología y hepatología 2009;32(9):591-9.
2009: carlos taxonera; Luis Rodrigo; Francesc Casellas; Xavier Calvet; Federico Gómez-Camacho; Daniel Ginard; Manuel Castro; Luisa Castro; Marta Ponce; Pilar Martínez-Montiel; Elena Ricart; Javier P Gisbert; Antonio López-San Román; José M Morales; Miguel A Casado
Infliximab maintenance therapy is associated with decreases in direct resource use in patients with luminal or fistulizing Crohn's disease.
Journal of clinical gastroenterology 2009;43(10):950-6.
2009: Javier P Gisbert; Adrian G McNicholl; Fernando Gomollón
Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease.
Inflammatory bowel diseases 2009;15(11):1746-54.
2009: Javier P Gisbert; Xavier Calvet
Review article: Helicobacter pylori-negative duodenal ulcer disease.
Alimentary pharmacology & therapeutics 2009;30(8):791-815.
2009: Fernando Gomollón; Javier P Gisbert
Anemia and inflammatory bowel diseases.
World journal of gastroenterology : WJG 2009;15(37):4659-65.
2009: Fernando Gomollón; Javier P Gisbert
Anemia and digestive diseases: an update for the clinician.
World journal of gastroenterology : WJG 2009;15(37):4615-6.
2009: Javier P Gisbert; Julián Panés
[The Hirsch's h-index: a new tool for measuring scientific production].
Cirugía española 2009;86(4):193-5.
2009: Javier P Gisbert; F Bermejo; Ramón Pajares; Jose-Lázaro Pérez-Calle; María Rodríguez; Alicia Algaba; Noemí Mancenido; Felipe de la Morena; Jose Antonio Carneros; Adrián G McNicholl; Yago González Lama; José Maté
Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement.
Inflammatory bowel diseases 2009;15(10):1485-91.
2009: Javier P Gisbert; F Bermejo; Jose-Lázaro Pérez-Calle; carlos taxonera; Isabel Vera; Adrian G McNicholl; Alicia Algaba; Pilar López; Natalia López-Palacios; Marta Calvo; Yago González Lama; Jose-Antonio Carneros; Marta Velasco; José Maté
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.
Inflammatory bowel diseases 2009;15(8):1190-8.
2009: David Gurwitz; Cristina Rodríguez-Antona; Katherine Payne; William Newman; Javier P Gisbert; Emma Gutiérrez de Mesa; Dolores Ibarreta
Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain.
European journal of human genetics : EJHG 2009;17(8):991-8.
2009: Juan-Alfonso Soler; Mercé Güell; Meritxell Bricullé; Antoni Gavarró; I Roig; Jordi Sanchez; Javier P Gisbert; Pilar García; Albert Villoria; Xavier Calvet
H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort study.
Annals of hematology 2009;88(8):769-73.
2009: Javier P Gisbert
Stomach: Quadruple therapy for Helicobacter pylori eradication.
Nature reviews. Gastroenterology & hepatology 2009;6(7):385-6.
2009: Emili Gené; Jordi Sanchez-Delgado; Xavier Calvet; Javier P Gisbert; Rafel Azagra
What is the best strategy for diagnosis and treatment of Helicobacter pylori in the prevention of recurrent peptic ulcer bleeding? A cost-effectiveness analysis.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(5):759-62.
2009: Javier P Gisbert; P M Linares; A G McNicholl; José Maté; Fernando Gomollón
Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis.
Alimentary pharmacology & therapeutics 2009;30(2):126-37.
2009: José Ignacio Fortea Ormaechea; Javier P Gisbert; Ignacio Marín-Jiménez
[Role of Mycobacterium avium paratuberculosis in the etiopathogenesis of Crohn's disease].
Gastroenterología y hepatología 2009;32(5):353-63.
2009: Javier P Gisbert; Miguel Fernández Bermejo; Javier Molina Infante; Belén Pérez Gallardo; Ana-Beatriz Prieto Bermejo; José-María Mateos Rodríguez; Pilar Robledo Andrés; Guadalupe González García
Levofloxacin, Amoxicillin, and Omeprazole as first-line triple therapy for Helicobacter pylori eradication.
Journal of clinical gastroenterology 2009;43(4):384-5.
2009: Javier P Gisbert; Julián Panés
[Scientific publication, bibliometric indicators, and Hirsch's h-index].
Gastroenterología y hepatología 2009;32(3):140-9.
2009: Javier P Gisbert; Julián Panés
Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review.
The American journal of gastroenterology 2009;104(3):760-7.
2009: Javier P Gisbert; Alun Cooper; Dimitrios Karagiannis; Jan Hatlebakk; Lars Agréus; Helmut Jablonowski; Javier Nuevo
Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study.
Health and quality of life outcomes 2009;7():90.
2009: Javier P Gisbert; Alun Cooper; Dimitrios Karagiannis; Jan Hatlebakk; Lars Agréus; Helmut Jablonowski; Javier Zapardiel
Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting.
Health and quality of life outcomes 2009;7():60.
2009: María Chaparro; Javier P Gisbert; Lourdes Del Campo; José Cantero; José Maté
Accuracy of computed tomographic colonography for the detection of polyps and colorectal tumors: a systematic review and meta-analysis.
Digestion 2009;80(1):1-17.
2008: Javier P Gisbert
[Helicobacter pylori-related diseases: dyspepsia, ulcer and gastric cancer].
Gastroenterología y hepatología 2008;31 Suppl 4():18-28.
2008: J Enrique Dominguez-Muñoz; Javier P Gisbert
[Introduction. The latest advances in gastroenterology].
Gastroenterología y hepatología 2008;31 Suppl 4():1-2.
2008: Javier P Gisbert; Blas Gómez; Joan Monés; Manuel Castro-Fernández; Pilar Sánchez-Pobre; Angel Cosme; Juan Manuel Herrerías; José María Pajares
Recurrence of Helicobacter pylori infection: 3650 patient-years follow-up study.
Helicobacter 2008;13(5):388.
2008: Javier P Gisbert; Marta Luna; Yago González Lama; Inés D Pousa; Marta Velasco; Ricardo Moreno-Otero; José Maté
Effect of 5-aminosalicylates on renal function in patients with inflammatory bowel disease: 4-year follow-up study.
Gastroenterología y hepatología 2008;31(8):477-84.
2008: Albert Villoria; P Garcia; Xavier Calvet; Javier P Gisbert; Mercedes Vergara
Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 2008;28(7):868-77.
2008: Yamile Zabana; Eugeni Domènech; Antonio López San Román; Belén Beltrán; José Luis Cabriada; Cristina Saro; Robert Araméndiz; Daniel Ginard; Joaquín Hinojosa; Javier P Gisbert; Míriam Mañosa; Eduard Cabré; Miquel A Gassull
Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy.
Inflammatory bowel diseases 2008;14(10):1387-91.
2008: Maria Esteve; Javier P Gisbert
Severe ulcerative colitis: at what point should we define resistance to steroids?
World journal of gastroenterology : WJG 2008;14(36):5504-7.
2008: Fernando Gomollón; Javier P Gisbert; Miquel Angel Gassull
Crohnology: a tale of time and times and inflammatory bowel diseases.
World journal of gastroenterology : WJG 2008;14(36):5489-90.
2008: Javier P Gisbert
"Rescue" regimens after Helicobacter pylori treatment failure.
World journal of gastroenterology : WJG 2008;14(35):5385-402.
2008: Jordi Sánchez-Delgado; X Calvet; Luis Bujanda; Javier P Gisbert; Llúcia Titó; Manuel Castro
Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.
The American journal of gastroenterology 2008;103(9):2220-3.
2008: F Bermejo; A Lopez-Sanroman; carlos taxonera; Javier P Gisbert; J L Pérez-Calle; I Vera; L Menchén; M D Martín-Arranz; V Opio; J A Carneros; M Van-Domselaar; J L Mendoza; M Luna; P López; M Calvo; A Algaba
Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
Alimentary pharmacology & therapeutics 2008;28(5):623-8.
2008: Maria Trapero-Marugan; M Marin; Juan Pablo Pivel; J M Del Rio; O Nunez; G Clemente; Javier P Gisbert; Ricardo Moreno-Otero
Predictive graphical model, network-based medical tool for the prognosis of chronic hepatitis C patients treated with peg-interferon plus ribavirin.
Alimentary pharmacology & therapeutics 2008;28(4):468-74.
2008: L Martín Martín; C Santander Vaquero; S Sánchez Prudencio; José Cantero Perona; Javier P Gisbert; Ricardo Moreno-Otero
[Eosinophilic esophagitis in the adult--clinical, endoscopic, pH-metric, and manometric findings].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2008;100(8):476-80.
2008: Yago González Lama; Antonio López-San Román; Ignacio Marín-Jiménez; Begoña Casis; Isabel Vera; F Bermejo; José Lázaro Pérez-Calle; carlos taxonera; Francisca Martínez-Silva; Luis Menchén; Pilar Martínez-Montiel; Marta Calvo; José Antonio Carneros; Pilar López; Juan Luis Mendoza; José María Milicua; Alaín Huerta; Fernando Sánchez; Luis Abreu; Natalia López-Palacios; José Maté; Javier P Gisbert
Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response.
Gastroenterología y hepatología 2008;31(7):421-6.
2008: Rosario López-Rodríguez; Jesús Novalbos; Sonia Gallego-Sandín; Manuel Román-Martínez; Juan Torrado; Javier P Gisbert; Francisco Abad-Santos
Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers.
Pharmacological research : the official journal of the Italian Pharmacological Society 2008;58(1):77-84.
2008: Javier P Gisbert; Fernando Gomollón
Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review.
The American journal of gastroenterology 2008;103(7):1783-800.
2008: Javier P Gisbert; P Niño; Carlos Cara; Luis Rodrigo
Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients.
Alimentary pharmacology & therapeutics 2008;28(2):228-38.
2008: Javier P Gisbert; Cecilio Santander; José María Piqué
[Questions and answers in gastroenterology].
Gastroenterología y hepatología 2008;31(6):388-9.
2008: Luis G Guijarro; Jose Mate; Javier P Gisbert; Jose Luis Perez-Calle; Ignacio Marin-Jimenez; Encarna Arriaza; Tomas Olleros; Mario Delgado; Maria S Castillejo; David Prieto-Merino; Venancio Gonzalez Lara; Amado Salvador Peña
N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study.
World journal of gastroenterology : WJG 2008;14(18):2851-7.
2008: Javier P Gisbert; Fernando Gomollón
Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease.
The American journal of gastroenterology 2008;103(5):1299-307.
2008: Javier P Gisbert; Pablo Alonso-Coello; Josep M Piqué
[How can we find, design, evaluate and use clinical practice guidelines?].
Gastroenterología y hepatología 2008;31(4):239-57.
2008: E Gómez-Dominguez; Jorge Mendoza; Luisa García-Buey; María Trapero-Marugán; Javier P Gisbert; E A Jones; Ricardo Moreno-Otero
Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.
Alimentary pharmacology & therapeutics 2008;27(5):441-7.
2008: Javier P Gisbert; Jose Luis Gisbert; Santiago Marcos; I Jimenez-Alonso; Ricardo Moreno-Otero; José María Pajares
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
Alimentary pharmacology & therapeutics 2008;27(4):346-54.
2008: Inés D Pousa; José Maté; Javier P Gisbert
Angiogenesis in inflammatory bowel disease.
European journal of clinical investigation 2008;38(2):73-81.
2008: J L Perez-Calle; I Marin-Jimenez; P Lopez-Serrano; Javier P Gisbert; Amado Salvador Peña; Conrado Fernandez-Rodriguez
Prevalence of macrocreatinkinase type 1 in patients with inflammatory bowel disease.
Digestive diseases and sciences 2008;53(2):486-9.
2008: Inés D Pousa; José Maté; Xamila Salcedo-Mora; Maria Abreu; Ricardo Moreno-Otero; Javier P Gisbert
Role of vascular endothelial growth factor and angiopoietin systems in serum of Crohn's disease patients.
Inflammatory bowel diseases 2008;14(1):61-7.
2008: Javier P Gisbert; Fernando Bermejo; Manuel Castro-Fernández; Angeles Pérez-Aisa; Miguel Fernández-Bermejo; Albert Tomas; José Barrio; Felipe Bory; Pedro Almela; Pilar Sánchez-Pobre; Angel Cosme; Vicente Ortiz; Pilar Niño; Sam Khorrami; Luis-Miguel Benito; JA Carneros; Eloisa Lamas; Inés Modolell; A Franco; Juan Ortuño; Luis Rodrigo; Fernando García-Durán; Elena O'Callaghan; Julio Ponce; María-Paz Valer; Xavier Calvet
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
The American journal of gastroenterology 2008;103(1):71-6.
2007: Javier P Gisbert; Ramón Pajares; José María Pajares
Evolution of Helicobacter pylori therapy from a meta-analytical perspective.
Helicobacter 2007;12 Suppl 2():50-8.
2007: Javier P Gisbert; Fernando Gomollón
[Common errors in the management of outpatients with inflammatory bowel disease].
Gastroenterología y hepatología 2007;30(8):469-86.
2007: Javier P Gisbert; Marta Luna; Yago González Lama; Inés D Pousa; Marta Velasco; Ricardo Moreno-Otero; José Maté
Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients.
Inflammatory bowel diseases 2007;13(9):1106-14.
2007: María Chaparro Sánchez; Lourdes del Campo Val; José Maté Jiménez; José Cantero Perona; Antonio Barbosa; David Olivares; Sam Khorrami; Ricardo Moreno-Otero; Javier P Gisbert
Computed tomography colonography compared with conventional colonoscopy for the detection of colorectal polyps.
Gastroenterología y hepatología 2007;30(7):375-80.
2007: Xavier Calvet; Mercedes Vergara; Javier P Gisbert; Enric Brullet
Dual versus endoscopic monotherapy in bleeding peptic ulcers.
The American journal of gastroenterology 2007;102(8):1826-7; author reply 1827-8.
2007: Javier P Gisbert; Xavier Calvet; Faust Feu; Felipe Bory; Angel Cosme; Pedro Almela; Santos Santolaria; Rosario Aznárez; Manuel Castro; Nuria Fernández; Rafael García-Grávalos; Nuria Cañete; Adolfo Benages; Miguel Montoro; Fernando Borda; Angeles Pérez-Aisa; Josep M Piqué
Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.
Helicobacter 2007;12(4):279-86.
2007: Javier P Gisbert; Miguel Fernández-Bermejo; Javier Molina Infante; Belén Pérez Gallardo; A-B Prieto-Bermejo; J-M Mateos-Rodríguez; Pilar Robledo Andrés; G González-García
First-line triple therapy with levofloxacin for Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 2007;26(3):495-500.
2007: L M Asenjo; Javier P Gisbert
[Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2007;99(7):398-404.
2007: Jorge Mendoza; J Legido; Saioa Rubio; Javier P Gisbert
Systematic review: the adverse effects of sodium phosphate enema.
Alimentary pharmacology & therapeutics 2007;26(1):9-20.
2007: Javier P Gisbert; Yago González Lama; José Maté
Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review.
The American journal of gastroenterology 2007;102(7):1518-27.
2007: Javier P Gisbert; Carlos Esteban; Isabel Jimenez; Ricardo Moreno-Otero
13C-urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding.
Helicobacter 2007;12(3):231-7.
2007: Javier P Gisbert; Fernando Gomollón
[Common errors in the management of the seriously ill patient with inflammatory bowel disease].
Gastroenterología y hepatología 2007;30(5):294-314.
2007: Javier P Gisbert; Fernando Gomollón; Carlos Cara; Marta Luna; Yago González Lama; José María Pajares; José Maté; Luis G Guijarro
Thiopurine methyltransferase activity in Spain: a study of 14,545 patients.
Digestive diseases and sciences 2007;52(5):1262-9.
2007: Javier P Gisbert; Yago González Lama; José Maté
5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review.
Inflammatory bowel diseases 2007;13(5):629-38.
2007: F De la Morena; L Martín; Javier P Gisbert; Jesús Fernández-Herrera; Rebeca Goiriz
Refractory and infected pyoderma gangrenosum in a patient with ulcerative colitis: response to infliximab.
Inflammatory bowel diseases 2007;13(4):509-10.
2007: Javier P Gisbert; Yago González Lama; José Maté
[Role of biological markers in inflammatory bowel disease].
Gastroenterología y hepatología 2007;30(3):117-29.
2007: Francesc Balaguer; Sergi Castellví-Bel; Antoni Castells; Montserrat Andreu; Jenifer Muñoz; Javier P Gisbert; Xavier Llor; Rodrigo Jover; Rafael de Cid; Victòria Gonzalo; Xavier Bessa; Rosa M Xicola; Elisenda Pons; Cristina Alenda; Artemio Payá; Josep M Piqué
Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(3):379-87.
2007: J M Pajares García; R Pajares-Villarroya; Javier P Gisbert
[Helicobacter pylori infection: antibiotic resistance].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2007;99(2):63-70.
2007: David Olivares; Javier P Gisbert; Carlos Gamallo; José Maté-Jiménez
Immunological changes at rectal mucosa in appendectomised subjects and inhabitants of developing countries.
Gastroenterología y hepatología 2007;30(2):57-60.
2007: Javier P Gisbert; Jose Luis Gisbert; Santiago Marcos; Ricardo Moreno-Otero; José María Pajares
Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure.
Helicobacter 2007;12(1):68-73.
2007: M Vergara; X Calvet; Javier P Gisbert
Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcers.
Cochrane database of systematic reviews (Online) 2007;(2):CD005584.
2007: Javier P Gisbert; Yago González Lama; José Maté
Systematic review: Infliximab therapy in ulcerative colitis.
Alimentary pharmacology & therapeutics 2007;25(1):19-37.
2006: Emili Gené; Xavier Calvet; Rafael Azagra; Javier P Gisbert
[Seven or ten days? Cost-effectiveness study on the duration of H. pylori treatment in primary care].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 2006;38(10):555-62.
2006: Javier P Gisbert; Pilar Niño; Luis Rodrigo; Carlos Cara; Luis G Guijarro
Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.
The American journal of gastroenterology 2006;101(12):2769-76.
2006: Javier P Gisbert; Jose Luis Gisbert; Santiago Marcos; Ricardo Moreno-Otero; José María Pajares
Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.
Alimentary pharmacology & therapeutics 2006;24(10):1469-74.
2006: Javier P Gisbert; Yago González Lama; José Maté
[Monitoring of thiopurine methyltransferase and thiopurine metabolites to optimize azathioprine therapy in inflammatory bowel disease].
Gastroenterología y hepatología 2006;29(9):568-83.
2006: J M Pajares; Javier P Gisbert
Helicobacter pylori: its discovery and relevance for medicine.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2006;98(10):770-85.
2006: Yago Gonzalez-Lama; Javier P Gisbert; Jose Mate
The role of tacrolimus in inflammatory bowel disease: a systematic review.
Digestive diseases and sciences 2006;51(10):1833-40.
2006: Javier P Gisbert; B Aguado; M Luna; S Nistal; L M Asenjo; T Reina; A Acevedo; Reyes Arranz
Gastric MALT lymphoma: clinical characteristics and prevalence of H. pylori infection in a series of 37 cases.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2006;98(9):655-65.
2006: Inés D Pousa; Javier P Gisbert; José Maté
[Vascular development in inflammatory bowel disease].
Gastroenterología y hepatología 2006;29(7):414-21.
2006: Javier P Gisbert; Guillermo Torrado; Susana Torrado; David Olivares; José María Pajares
Clinical trial evaluating amoxicillin and clarithromycin hydrogels (Chitosan-polyacrylic acid polyionic complex) for H. pylori eradication.
Journal of clinical gastroenterology 2006;40(7):618-22.
2006: Javier P Gisbert; Felipe de la Morena; Víctor Abraira
Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis.
The American journal of gastroenterology 2006;101(8):1921-30.
2006: A J del Pozo García; Javier P Gisbert
Is the string test a useful alternative to gastroscopy with biopsy for H. pylori identification?
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2006;98(7):542-9.
2006: I D Pousa; Javier P Gisbert
Gastric angiogenesis and Helicobacter pylori infection.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2006;98(7):527-41.
2006: Elena Gómez-Domínguez; Luisa García-Buey; Javier P Gisbert; Ricardo Moreno-Otero
Lamivudine response of IgM anti-HBc chronic hepatitis B patients.
Alimentary pharmacology & therapeutics 2006;23(12):1757-8; author reply 1758-60.
2006: Javier P Gisbert
[Pharmacological treatment of bleeding peptic ulcer].
Medicina clínica 2006;127(2):66-75.
2006: Elena Gómez-Domínguez; Javier P Gisbert; José A Moreno-Monteagudo; Luisa García-Buey; Ricardo Moreno-Otero
A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients.
Alimentary pharmacology & therapeutics 2006;23(11):1643-7.
2006: D Olivares; Javier P Gisbert
Factors involved in the pathogenesis of Helicobacter pylori infection.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2006;98(5):374-86.
2006: Elena Gómez-Domínguez; María Trapero-Marugán; A J del Pozo; José Cantero; Javier P Gisbert; José Maté
The colorectal carcinoma prognosis factors. Significance of diagnosis delay.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2006;98(5):322-9.
2006: Javier P Gisbert; Marta Luna; José Maté; Luis González-Guijarro; Carlos Cara; José María Pajares
Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
Hepato-gastroenterology 2006;53(69):399-404.
2006: María-Encarnación Fernández-Contreras; Sandra Sánchez-Prudencio; José-Javier Sánchez-Hernández; María-Luisa García de Paredes; Javier P Gisbert; Pedro Roda-Navarro; Carlos Gamallo
Thymidylate synthase expression pattern, expression level and single nucleotide polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with 5-fluorouracil.
International journal of oncology 2006;28(5):1303-10.
2006: María Trapero-Marugán; Javier P Gisbert; José María Pajares
Spanish scientific output on Helicobacter pylori. A study through Medline.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2006;98(4):255-64.
2006: Javier P Gisbert; Víctor Abraira
Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis.
The American journal of gastroenterology 2006;101(4):848-63.
2006: Javier P Gisbert; David Olivares; I Jimenez; José María Pajares
Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2006;38(4):254-9.
2006: Javier P Gisbert; M Luna; B Gómez; J M Herrerías; J Monés; Manuel Castro-Fernández; P Sánchez-Pobre; Angel Cosme; D Olivares; J M Pajares
Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients.
Alimentary pharmacology & therapeutics 2006;23(6):713-9.
2006: Javier P Gisbert; Manuel Castro-Fernández; Fernando Bermejo; Angeles Pérez-Aisa; Julio Ducons; Miguel Fernández-Bermejo; Felipe Bory; Angel Cosme; Luis-Miguel Benito; Laureano López-Rivas; Eloisa Lamas; Manuel Pabón; David Olivares
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
The American journal of gastroenterology 2006;101(2):243-7.
2006: Javier P Gisbert; Jesús Legido; Isabel Castel; María Trapero-Marugán; José Cantero; José Maté; José María Pajares
Risk assessment and outpatient management in bleeding peptic ulcer.
Journal of clinical gastroenterology 2006;40(2):129-34.
2006: Javier P Gisbert; David Olivares; I Jimenez; José María Pajares
Long-term follow-up of 13C-urea breath test results after Helicobacter pylori eradication: frequency and significance of borderline delta13CO2 values.
Alimentary pharmacology & therapeutics 2006;23(2):275-80.
2006: Xamila Salcedo-Mora; José Maté; Jesús Medina; Syong J Nam Cha; Javier P Gisbert; Ricardo Moreno-Otero
Chronic hepatitis C and Crohn's disease: nosocomial infection treatment with PEG-interferon plus ribavirin.
Digestion 2006;73(4):210-4.
2006: Javier P Gisbert; F Morena
Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.
Alimentary pharmacology & therapeutics 2006;23(1):35-44.
2005: Javier P Gisbert; María Trapero-Marugán; José María Pajares
Evaluation of 3 different tests for the detection of stool antigens to confirm Helicobacter pylori eradication after treatment. A pilot study.
Gastroenterología y hepatología 2005;28(10):615-8.
2005: Javier P Gisbert; José María Pajares
13C-urea breath test in the management of Helicobacterpylori infection.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2005;37(12):899-906.
2005: Javier P Gisbert; Jose Luis Gisbert; Santiago Marcos; D Olivares; José María Pajares
Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin.
Alimentary pharmacology & therapeutics 2005;22(10):1041-6.
2005: Jesús Legido; Javier P Gisbert; José María Pajares; José Maté
Bone metabolism changes in patients with inflammatory bowel disease.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2005;97(11):815-29.
2005: Javier P Gisbert
[Prevention of bleeding recurrence in peptic ulcer by Helicobacter pylori eradication].
Gastroenterología y hepatología 2005;28(9):567-75.
2005: Javier P Gisbert; José María Pajares
Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
Helicobacter 2005;10(5):363-72.
2005: Javier P Gisbert
Rescue therapy with levofloxacin after multiple H. pylori treatment failures.
Alimentary pharmacology & therapeutics 2005;22(7):653-4; author reply 654-5.
2005: Javier P Gisbert; Francisco Abad-Santos; Jesús Novalbos; Sam Khorrami; Sonia Gallego-Sandín; Aránzazu Rosado; M Angeles Gálvez-Múgica; José María Pajares
Comparison of gastric endoscopic lesions and tolerability to ibuprofen and ibuprofen-arginate in healthy subjects.
Journal of clinical gastroenterology 2005;39(9):834-5.
2005: Javier P Gisbert; Xavier Calvet; Fernando Gomollón; Joan Monés
[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference].
Medicina clínica 2005;125(8):301-16.
2005: Javier P Gisbert; Fernando Gomollón; Carlos Cara; Marta Luna; Yago González Lama; José María Pajares; José Maté; Luis G Guijarro
[Thiopurine methyltransferase activity in inflammatory bowel disease. A study on 7046 Spanish patients].
Medicina clínica 2005;125(8):281-5.
2005: Javier P Gisbert
The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review.
The American journal of gastroenterology 2005;100(9):2083-99.
2005: Javier P Gisbert; Antonio Domínguez-Muñoz; Antonio Domínguez-Martín; Jose Luis Gisbert; Santiago Marcos
Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment?
The American journal of gastroenterology 2005;100(9):1935-40.
2005: Javier P Gisbert; Yago González Lama
[Breath tests in the diagnosis of gastrointestinal diseases].
Gastroenterología y hepatología 2005;28(7):407-16.
2005: Xavier Calvet; Julio Ducons; L Bujanda; Felipe Bory; Antònia Montserrat; Javier P Gisbert
Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.
The American journal of gastroenterology 2005;100(8):1696-701.
2005: D Olivares; Javier P Gisbert; José María Pajares
Helicobacter pylori infection and gastric mucosal epithelial cell apoptosis.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2005;97(7):505-20.
2005: Mercedes Vergara; M Catalán; Javier P Gisbert; Xavier Calvet
Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
Alimentary pharmacology & therapeutics 2005;21(12):1411-8.
2005: Javier P Gisbert; Leticia Gonzalez; Xavier Calvet
Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
Helicobacter 2005;10(3):157-71.
2005: Javier P Gisbert; J Fuentes; D Carpio; Llucia Tito; Jordi Guardiola; A Tomas; D Olivares; Xavier Calvet
7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
Alimentary pharmacology & therapeutics 2005;21(10):1249-53.
2005: Javier P Gisbert; Josep M Piqué
[Indications and consequences of Helicobacter pylori eradication on gastroesophageal reflux disease].
Medicina clínica 2005;124(18):697-709.
2005: Joan Monés; Javier P Gisbert; F Borda; E Domínguez-Muñoz
Indications, diagnostic tests and Helicobacter pylori eradication therapy. Recommendations by the 2nd Spanish Consensus Conference.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2005;97(5):348-74.
2005: Javier P Gisbert
How effective are rescue H. pylori eradication therapies in patients with dyspepsia?
Nature clinical practice. Gastroenterology & hepatology 2005;2(4):180-1.
2005: Javier P Gisbert; José María Pajares
Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer?
Alimentary pharmacology & therapeutics 2005;21(7):795-804.
2005: Javier P Gisbert; Luisa García-Buey; J M Pajares; Ricardo Moreno-Otero
Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection.
Alimentary pharmacology & therapeutics 2005;21(6):653-62.
2005: Javier P Gisbert
Potent gastric acid inhibition in Helicobacter pylori eradication.
Drugs 2005;65 Suppl 1():83-96.
2005: S Khorrami Mashhadi; María Trapero-Marugán; Javier P Gisbert; E Gómez Domínguez; J Maté Jiménez
A pilot study on the endoscopic surveillance of colorectal dysplasia and cancer in long-standing ulcerative colitis.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2005;97(1):16-23.
2004: Javier P Gisbert; José María Pajares
Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review.
Alimentary pharmacology & therapeutics 2004;20(10):1001-17.
2004: Sonia Gallego-Sandín; Jesús Novalbos; Aránzazu Rosado; Javier P Gisbert; M Angeles Gálvez-Múgica; Antonio G García; José María Pajares; Francisco Abad-Santos
Effect of ibuprofen on cyclooxygenase and nitric oxide synthase of gastric mucosa: correlation with endoscopic lesions and adverse reactions.
Digestive diseases and sciences 2004;49(9):1538-44.
2004: Javier P Gisbert; José María Pajares
Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review.
Helicobacter 2004;9(4):347-68.
2004: Javier P Gisbert; Luisa García-Buey; Alejandro Alonso; Saioa Rubio; Almudena Hernández; José María Pajares; Amaro García-Díez; Ricardo Moreno-Otero
Hepatocellular carcinoma risk in patients with porphyria cutanea tarda.
European journal of gastroenterology & hepatology 2004;16(7):689-92.
2004: M Luna-Chadid; JL Pérez Calle; Juan L Mendoza; Maria Isabel Vera; A F Bermejo; F Sánchez; A López San Román; C Froilán; V González-Lara; J García Paredes; I Fernández-Blanco; Luis E Abreu; B Casis; José A Solís-Herruzo; Javier P Gisbert; J Maté Jiménez
Predictors of response to infliximab in patients with fistulizing Crohn's disease.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2004;96(6):379-81; 382-4.
2004: María Teresa Arroyo; Montse Forne; Carlos Martin de Argila; Faust Feu; Juan Arenas; Juan de la Vega; Vicente Garrigues; Francisco Mora; Manuel Castro; Luis Bujanda; Angel Cosme; Agustín Castiella; Javier P Gisbert; Antonio Hervas; Angel Lanas
The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Helicobacter 2004;9(3):249-54.
2004: Javier P Gisbert; María Trapero-Marugán; Xavier Calvet; Jorge Mendoza; M Quesada; Mercé Güell; José María Pajares
Evaluation of three different tests for the detection of stool antigens to diagnose Helicobacter pylori infection in patients with upper gastrointestinal bleeding.
Alimentary pharmacology & therapeutics 2004;19(8):923-9.
2004: Javier P Gisbert; José María Pajares
Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2004;36(4):253-9.
2004: Javier P Gisbert; Sam Khorrami; F Carballo; Xavier Calvet; E Gene; E Dominguez-Muñoz
Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
Alimentary pharmacology & therapeutics 2004;19(6):617-29.
2004: Javier P Gisbert; X Bonfil; X Bonfill
[Systematic reviews and meta-analyses: how should they be performed, evaluated and used?].
Gastroenterología y hepatología 2004;27(3):129-49.
2004: Javier P Gisbert; Marta Luna; Jesús Legido; Carlos Hermida; José Maté; José María Pajares
[Anti-neutrophil cytoplasmic antibodies in the diagnosis of ulcerative colitis and Crohn's disease].
Medicina clínica 2004;122(4):134-5.
2004: Javier P Gisbert; Xavier Badía; Montse Roset; José María Pajares
The TETRA study: a prospective evaluation of Helicobacter pylori 'test-and-treat' strategy on 736 patients in clinical practice.
Helicobacter 2004;9(1):28-38.
2004: Javier P Gisbert; Luisa García-Buey; Reyes Arranz; Carlos Blas; Inmaculada Pinilla; Sam Khorrami; Agustín Acevedo; María J Borque; José María Pajares; José María Fernández-Rañada; Ricardo Moreno-Otero
The prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma.
European journal of gastroenterology & hepatology 2004;16(2):135-8.
2004: Javier P Gisbert; J Legido; I García-Sanz; José María Pajares
Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2004;36(2):116-20.
2004: Xavier Calvet; Mercedes Vergara; Enric Brullet; Javier P Gisbert; Rafel Campo
Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers.
Gastroenterology 2004;126(2):441-50.
2004: Javier P Gisbert; Sam Khorrami; F Carballo; Xavier Calvet; Emili Gené; J E Dominguez-Muñoz
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
Cochrane database of systematic reviews (Online) 2004;(2):CD004062.
2004: Javier P Gisbert; Sam Khorrami; Xavier Calvet; José María Pajares
Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis.
European journal of gastroenterology & hepatology 2004;16(1):89-99.
2004: Javier P Gisbert; Ana Isabel Cruzado; Rafael Garcia-Gravalos; José María Pajares
Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
Hepato-gastroenterology 2004;51(55):303-8.
2004: Javier P Gisbert; Jose Luis Gisbert; Santiago Marcos; José María Pajares
Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2004;36(1):7-12.
2003: Javier P Gisbert; Luisa García-Buey; José María Pajares; Ricardo Moreno-Otero
Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis.
Gastroenterology 2003;125(6):1723-32.
2003: Javier P Gisbert; Luis González-Guijarro; Carlos Cara; José María Pajares; Ricardo Moreno-Otero
[Thiopurine methyltransferase activity in patients with autoimmune hepatitis].
Medicina clínica 2003;121(13):481-4.
2003: Javier P Gisbert; Sam Khorrami; Xavier Calvet; R Gabriel; F Carballo; José María Pajares
Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists--their efficacy with antibiotics in Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 2003;18(8):757-66.
2003: Javier P Gisbert; Luisa García-Buey; José María Pajares; Ricardo Moreno-Otero
Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis.
Journal of hepatology 2003;39(4):620-7.
2003: Mercedes Vergara; M Vallve; Javier P Gisbert; Xavier Calvet
Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 2003;18(6):647-54.
2003: Emili Gené; Xavier Calvet; Rafael Azagra; Javier P Gisbert
Triple vs quadruple therapy for treating Helicobacter pylori infection: an updated meta-analysis.
Alimentary pharmacology & therapeutics 2003;18(5):543-4.
2003: Javier P Gisbert; Marta Luna; José Maté; Luis González-Guijarro; Carlos Cara; José María Pajares
[Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine].
Medicina clínica 2003;121(1):1-5.
2003: Javier P Gisbert; José María Pajares
Helicobacter pylori infection and perforated peptic ulcer prevalence of the infection and role of antimicrobial treatment.
Helicobacter 2003;8(3):159-67.
2003: Emili Gené; Xavier Calvet; Rafael Azagra; Javier P Gisbert
Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis.
Alimentary pharmacology & therapeutics 2003;17(9):1137-43.
2003: Javier P Gisbert; Fernando Gomollón; José Maté; José María Pajares
[The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease].
Gastroenterología y hepatología 2003;26(5):312-24.
2003: Javier P Gisbert; José María Pajares
[Cyclooxygenase-2 and gastroduodenal lesions. Any relationship with Helicobacter pylori ? A systematic review].
Medicina clínica 2003;120(14):550-8.
2003: Javier P Gisbert; Xavier Calvet; Luis Bujanda; Santiago Marcos; Jose Luis Gisbert; José María Pajares
'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures.
Helicobacter 2003;8(2):90-4.
2003: Javier P Gisbert; Sam Khorrami; Xavier Calvet; José María Pajares
Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication.
Alimentary pharmacology & therapeutics 2003;17(6):751-64.
2003: Javier P Gisbert; José María Pajares
Attitude facing a patient suffering from Helicobacter pylori infection resistant to a triple therapy.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2003;95(3):220-8, 210-19.
2003: Javier P Gisbert; Fernando Gomollón; J E Domínguez-Muñoz; Fernando Borda; I Jiménez; M A Vázquez; S Gallego; J Iglesias; G Pastor; J M Pajares
[Comparison between two 13C-urea breath tests for the diagnosis of Helicobacter pylori infection: isotope ratio mass spectrometer versus infrared spectrometer].
Gastroenterología y hepatología 2003;26(3):141-6.
2003: Javier P Gisbert; José María Pajares
[Helicobacter pylori, cyclooxygenase-2 and gastric cancer].
Medicina clínica 2003;120(5):189-93.
2003: Javier P Gisbert; Julio Ducons; Fernando Gomollón; J E Domínguez-Muñoz; Fernando Borda; G Miño; I Jiménez; M A Vázquez; Santos Santolaria; S Gallego; J Iglesias; G Pastor; A Hervás; J M Pajares
Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2003;95(2):121-6, 115-20.
2003: J M Pajares García; Javier P Gisbert
Gastric carcinogenesis and Helicobacter pylori infection.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2003;95(2):84-88, 79-83.
2003: Javier P Gisbert; Sam Khorrami; F Carballo; Xavier Calvet; Emili Gené; J E Dominguez-Muñoz
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
Cochrane database of systematic reviews (Online) 2003;(4):CD004062.
2003: Javier P Gisbert; José María Pajares
Helicobacter pylori and bleeding peptic ulcer: what is the prevalence of the infection in patients with this complication?
Scandinavian journal of gastroenterology 2003;38(1):2-9.
2003: Alfonso Canete; Yamil Abunají; Guillermo Alvarez-Calatayud; Mercedes DeVicente; José A González-Holguera; María Leralta; José M Pajares; Javier P Gisbert
Breath test using a single 50-mg dose of 13C-urea to detect Helicobacter pylori infection in children.
Journal of pediatric gastroenterology and nutrition 2003;36(1):105-11.
2003: Javier P Gisbert; E Anthony Jones; José María Pajares; Ricardo Moreno-Otero
Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?
Alimentary pharmacology & therapeutics 2003;17(1):17-27.
2002: Javier P Gisbert; M A Vázquez; J Cantero; J M Pajares
[Study of the validity of "rapid" serology in diagnosing Helicobacter pylori infection].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 2002;30(8):501-6.
2002: Javier P Gisbert; José María Pajares; Ricardo Moreno-Otero
[Treatment of alcoholic hepatitis with corticosteroids. Are they really effective?].
Medicina clínica 2002;119(15):590-5.
2002: Javier P Gisbert; Fernando Gomollón; José Maté; J M Figueroa; R Alós; José María Pajares
[Treatment of stenosis due to Crohn's disease].
Gastroenterología y hepatología 2002;25(9):560-9.
2002: Javier P Gisbert; Ricardo Moreno-Otero; José María Pajares
[Prevalence of Helicobacter pylori infection in chronic liver disease and relationship with its complications: systematic review and meta-analysis].
Medicina clínica 2002;119(12):464-74.
2002: Javier P Gisbert; Fernando Gomollón; José Maté; José María Pajares
[Individualized therapy with azathioprine or 6-mercaptopurine by monitoring thiopurine methyl-transferase (TPMT) activity].
Revista clínica española 2002;202(10):555-62.
2002: Javier P Gisbert; Isabel García Arata; Daniel Boixeda; Mercedes Barba; Rafael Cantón; Antonio García Plaza; José María Pajares
Role of partner's infection in reinfection after Helicobacter pylori eradication.
European journal of gastroenterology & hepatology 2002;14(8):865-71.
2002: Javier P Gisbert; José María Pajares
[Prevalence of Helicobacter pylori infection in gastroesophageal reflux disease and Barretts esophagus].
Medicina clínica 2002;119(6):217-23.
2002: Javier P Gisbert; José María Pajares
Review article: Helicobacter pylori infection and gastric outlet obstruction - prevalence of the infection and role of antimicrobial treatment.
Alimentary pharmacology & therapeutics 2002;16(7):1203-8.
2002: Javier P Gisbert; Fernando Gomollón; José Maté; José María Pajares
[Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].
Gastroenterología y hepatología 2002;25(6):401-15.
2002: M Vallve; M Vergara; Javier P Gisbert; X Calvet
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
Alimentary pharmacology & therapeutics 2002;16(6):1149-56.
2002: Javier P Gisbert; José María Pajares
Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.
Alimentary pharmacology & therapeutics 2002;16(6):1047-57.
2002: Javier P Gisbert; Ignacio Llorca; José Cantero; José María Pajares
[Clinical and endoscopic prognostic factors in patients with bleeding peptic ulcer].
Medicina clínica 2002;118(13):481-6.
2002: Javier P Gisbert; Xavier Calvet; Rafael Gabriel; José María Pajares
[Helicobacter pylori infection and functional dyspepsia. Meta-analysis of efficacy of eradication therapy].
Medicina clínica 2002;118(11):405-9.
2002: Javier P Gisbert; María del Mar Cabrera Md; José María Pajares
[Stool antigen test for initial Helicobacter pylori diagnosis and for confirmation of eradication after therapy].
Medicina clínica 2002;118(11):401-4.
2002: Fernando Bermejo; Daniel Boixeda; Javier P Gisbert; Víctor Defarges; Jesús M Sanz; Carolina Redondo; Carlos Martiní de Argila; Antonio García Plaza
Rapid urease test utility for Helicobacter pylori infection diagnosis in gastric ulcer disease.
Hepato-gastroenterology 2002;49(44):572-5.
2002: Javier P Gisbert; Fernando Gomollón; José Maté; José María Pajares
Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.
Digestive diseases and sciences 2002;47(3):471-88.
2002: Dino Vaira; Nimish Vakil; Marcello Menegatti; Ben van't Hoff; Chiara Ricci; Luigi Gatta; Giovanni Gasbarrini; Mario Quina; Jose M Pajares Garcia; Arie van der Ende; Rene van Der Hulst; Marcello Anti; Cristina Duarte; Javier P Gisbert; Mario Miglioli; Guido Tytgat
The stool antigen test for detection of Helicobacter pylori after eradication therapy.
Annals of internal medicine 2002;136(4):280-7.
2002: Javier P Gisbert; José María Pajares
[Rapid whole blood test for the diagnosis of H. pylori infection. Can it be recommended for the diagnosis of the infection in clinical practice?].
Medicina clínica 2002;118(5):196-7.
2002: Tania Valmaseda; Javier P Gisbert; Manuel Paniagua; José M Pajares
[Helicobacter pylori CagA antibodies in various gastroduodenal diseases from 2 different populations].
Medicina clínica 2002;118(3):90-3.
2001: Javier P Gisbert; José María Pajares
[Should Helicobacter pylori infection be treated prior to long-term proton pump inhibitor therapy?].
Medicina clínica 2001;117(20):793-7.
2001: J Valle; Javier P Gisbert
Helicobacter pylori infection and precancerous lesions of the stomach.
Hepato-gastroenterology 2001;48(42):1548-51.
2001: Javier P Gisbert; Santiago Marcos; Jose Luis Gisbert; José María Pajares
Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
European journal of gastroenterology & hepatology 2001;13(11):1303-7.
2001: Javier P Gisbert; Ana Isabel Cruzado; LM Benito; D Carpio; J J Perez-Poveda; L Gonzalez; A de Pedro; M Valbuena; B Prieto; MM Cabrera; J Cantero; José María Pajares
Helicobacter pylori "test-and-scope" strategy for dyspeptic patients. Is it useful and safe?
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2001;33(7):539-45.
2001: Javier P Gisbert; J M Pajares
Diagnosis of Helicobacter pylori infection by stool antigen determination: a systematic review.
The American journal of gastroenterology 2001;96(10):2829-38.
2001: Javier P Gisbert; C Hermida; José María Pajares
Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia?
Hepato-gastroenterology 2001;48(41):1383-8.
2001: Javier P Gisbert; José María Pajares
[Bleeding peptic ulcer. Can the prognosis be accurately estimated and the hospitalization prevented?].
Medicina clínica 2001;117(6):227-32.
2001: T Valmaseda Pérez; Javier P Gisbert; J M Pajares García
Geographic differences and the role of cagA gene in gastroduodenal diseases associated with Helicobacter pylori infection.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2001;93(7):471-80.
2001: Javier P Gisbert; L Gonzalez; A de Pedro; M Valbuena; B Prieto; I Llorca; R Briz; S Khorrami; R Garcia-Gravalos; José María Pajares
Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Scandinavian journal of gastroenterology 2001;36(7):717-24.
2001: Xavier Calvet; Emili Gené; T López; Javier P Gisbert
What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis.
Alimentary pharmacology & therapeutics 2001;15(7):1067-76.
2001: Javier P Gisbert; L González; Xavier Calvet; M Roqué; R Gabriel; José María Pajares
Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.
Alimentary pharmacology & therapeutics 2001;15(7):917-26.
2001: Javier P Gisbert; Santiago Marcos; Jose Luis Gisbert; José María Pajares
High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication.
Helicobacter 2001;6(2):157-62.
2001: Javier P Gisbert; Fernando Gomollón; José Maté; J María Pajares
[Pharmacological treatment of fistulae in Crohn's disease].
Medicina clínica 2001;116(17):664-71.
2001: Javier P Gisbert; A de Pedro; C Losa; A Barreiro; José María Pajares
Helicobacter pylori and gastroesophageal reflux disease: lack of influence of infection on twenty-four-hour esophageal pH monitoring and endoscopic findings.
Journal of clinical gastroenterology 2001;32(3):210-4.
2001: F Bermejo; Daniel Boixeda; Javier P Gisbert; Jesús M Sanz; Víctor Defarges; G Alvarez Calatayud; L Moreno; Carlos Martín de Argila
[Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication].
Gastroenterología y hepatología 2001;24(2):56-62.
2001: Javier P Gisbert; J María Pajares
[Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review].
Medicina clínica 2001;116(3):111-6.
2001: Javier P Gisbert; José María Pajares
Helicobacter pylori therapy: first-line options and rescue regimen.
Digestive diseases (Basel, Switzerland) 2001;19(2):134-43.
2001: José María Pajares; Javier P Gisbert
Epidemiology of inflammatory bowel disease in Spain. A systematic review.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2001;93(1):9-20.
2000: Javier P Gisbert; M Blanco; Ana Isabel Cruzado; José María Pajares
Helicobacter pylori infection, gastric metaplasia in the duodenum and the relationship with ulcer recurrence.
European journal of gastroenterology & hepatology 2000;12(12):1295-8.
2000: Javier P Gisbert; L M Benito; S Lara; A Vázquez; I Jiménez; José María Pajares
13C-urea breath test for the diagnosis of Helicobacter pylori infection: are basal samples necessary?
European journal of gastroenterology & hepatology 2000;12(11):1201-5.
2000: Javier P Gisbert; L González; Xavier Calvet; N García; T López; M Roqué; R Gabriel; José María Pajares
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori.
Alimentary pharmacology & therapeutics 2000;14(10):1319-28.
2000: Javier P Gisbert; M Blanco; José María Pajares
[Effect of Helicobacter pylori eradication on histological lesions of gastric mucosa. An 18-month follow-up study].
Revista clínica española 2000;200(9):480-4.
2000: F Bermejo San José; D Boixeda de Miguel; Javier P Gisbert; C Martin de Argila de Prados; J M Sanz Sacristán; V Defarges Pons; L Moreno Almazán; A García Plaza Plaza
[Efficacy of four widely used techniques of the diagnosis of Helicobacter pylori infection in gastric ulcer disease].
Revista clínica española 2000;200(9):475-9.
2000: F Bermejo; Daniel Boixeda; Javier P Gisbert; Jesús M Sanz; R Cantón; Víctor Defarges; Carlos Martín de Argila
Concordance between noninvasive tests in detecting Helicobacter pylori and potential use of serology for monitoring eradication in gastric ulcer.
Journal of clinical gastroenterology 2000;31(2):137-41.
2000: Javier P Gisbert; L González; Xavier Calvet; M Roqué; R Gabriel; José María Pajares
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
Alimentary pharmacology & therapeutics 2000;14(9):1141-50.
2000: Javier P Gisbert; C Losa; A Barreiro; José María Pajares
Esophageal achalasia. Review of its clinical, diagnostic and therapeutic aspects.
Revista clínica española 2000;200(8):424-31.
2000: F Bermejo; Daniel Boixeda; Javier P Gisbert; Víctor Defarges; Carlos Martín de Argila; Jesús M Sanz; Antonio García Plaza
[Effects of Helicobacter pylori eradication on the recurrence of gastric ulcer during a 12-month follow up].
Medicina clínica 2000;115(6):201-4.
2000: Javier P Gisbert
[Diagnosis of Helicobacter pylori infection].
Revista clínica española 2000;200(7):370-2.
2000: F Bermejo; Daniel Boixeda; Javier P Gisbert; Jesús M Sanz; Víctor Defarges; G Alvarez Calatayud; Carlos Martín de Argila
[Gastric mucosa lesions in gastric ulcer disease. Initial study and 1-year follow-up after Helicobacter pylori eradication].
Gastroenterología y hepatología 2000;23(6):269-74.
2000: Javier P Gisbert; M Blanco; L M Benito; José María Pajares
Value of quantitative serology for confirmation of Helicobacter pylori eradication: an 18-month follow-up study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(6):976-80.
2000: Javier P Gisbert; José María Pajares
Helicobacter pylori "test-and-scope" strategy for dyspeptic patients.
Helicobacter 2000;5(2):57-68.
2000: J M Pajares; Javier P Gisbert
Role of interleukin-8 activity and phenotype in the pathogenesis of antral gastritis associated with Helicobacter pylori.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2000;92(5):295-300.
2000: Javier P Gisbert; D Carpio; Santiago Marcos; Jose Luis Gisbert; Rafael García-Grávalos; José María Pajares
One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
European journal of gastroenterology & hepatology 2000;12(5):489-95.
2000: Xavier Calvet; N García; T López; Javier P Gisbert; Emili Gené; M Roque
A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection.
Alimentary pharmacology & therapeutics 2000;14(5):603-9.
2000: R García Valriberas; Javier P Gisbert; Carmen Hermida; MM Cabrera; J Díaz Blasco; José María Pajares
[Antibodies against Helicobacter pylori in saliva. Study of their validity versus breath test and its agreement with serology].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 2000;25(6):390-4.
2000: S Lara Baruque; M Razquin; I Jimenez; A Vazquez; Javier P Gisbert; José María Pajares
13C-phenylalanine and 13C-methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2000;32(3):226-32.
2000: Javier P Gisbert; Ana Isabel Cruzado; MM Cabrera; D Carpio; LM Benito; JJ Pérez Poveda; M Valbuena; J Cantero; José María Pajares
["Rapid" serology for the diagnosis of Helicobacter pylori infection. Evaluation of its accuracy compared with a gold-standard and its concordance with "classic" serology].
Gastroenterología y hepatología 2000;23(4):159-64.
2000: Javier P Gisbert
[A critical review of the diagnostic methods for Helicobacter pylori infection].
Gastroenterología y hepatología 2000;23(3):135-43.
2000: Javier P Gisbert; X Calvet; F Gomollón; R Sáinz
[Treatment for the eradication of Helicobacter pylori. Recommendations of the Spanish Consensus Conference].
Medicina clínica 2000;114(5):185-95.
2000: JJ Pérez Poveda; Javier P Gisbert; JM Pajares García
[Helicobacter pylori and ischemic cardiopathy].
Gastroenterología y hepatología 2000;23(2):99-103.
2000: Javier P Gisbert; M A Vazquez; I Jimenez; Ana Isabel Cruzado; D Carpio; E Del Castillo; M J Martin; A Morales; R Pajares; A Rodriguez; José María Pajares
13C-urea breath test for the diagnosis of Helicobacter pylori infection before treatment: is citric acid necessary?
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2000;32(1):20-4.
2000: Javier P Gisbert; J M Pajares
[Clinical Trials in gastroenterology related to Helicobacter pylori infection].
Acta gastroenterologica Latinoamericana 2000;30(3):195-204.
2000: J M Pajares; Javier P Gisbert
[Is a 1-week treatment enough and safe for the healing of peptic ulcer?].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 2000;92(1):1-4.
1999: R Sainz; Fernando Borda; E Domínguez; Javier P Gisbert
[Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1999;91(11):777-84.
1999: Javier P Gisbert; M Blanco; J M Mateos; LI Fernández Salazar; M Fernández-Bermejo; J Cantero; José María Pajares
H. pylori-negative duodenal ulcer prevalence and causes in 774 patients.
Digestive diseases and sciences 1999;44(11):2295-302.
1999: Javier P Gisbert; Jose Luis Gisbert; Santiago Marcos; R G Grávalos; D Carpio; José María Pajares
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
Alimentary pharmacology & therapeutics 1999;13(10):1311-6.
1999: Javier P Gisbert; Daniel Boixeda; F Bermejo; M Nieves Rincón; M Jesús Higes; M Angeles Arpa; I García-Arata; Carlos Martín de Argila; Antonio García Plaza
Re-treatment after Helicobacter pylori eradication failure.
European journal of gastroenterology & hepatology 1999;11(9):1049-54.
1999: Javier P Gisbert
[Helicobacter pylori infection: a single microorganism with many consequences].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1999;91(8):537-40.
1999: Javier P Gisbert; J M Pajares
[Should H. pylori infection in duodenal ulcer be confirmed before administering eradicating treatment?].
Medicina clínica 1999;113(4):134-7.
1999: Javier P Gisbert; José María Pajares
[Are all H. pylori "bad"?].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1999;91(7):508-15.
1999: Javier P Gisbert; José María Pajares
Helicobacter pylori test-and-treat' strategy for dyspeptic patients.
Scandinavian journal of gastroenterology 1999;34(7):644-52.
1999: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila; Antonio García Plaza
[Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments].
Medicina clínica 1999;112(10):365-7.
1999: Javier P Gisbert; José María Pajares; C Losa
Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
Hepato-gastroenterology 1999;46(26):1023-9.
1999: Javier P Gisbert; José María Pajares; J Valle
Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review.
Helicobacter 1999;4(1):58-66.
1999: Joan Monés; Carlos Martín de Argila; R S Samitier; Javier P Gisbert; S Sainz; Daniel Boixeda
Prevalence of Helicobacter pylori infection in medical professionals in Spain.
European journal of gastroenterology & hepatology 1999;11(3):239-42.
1999: F Bermejo; L Moreno; Víctor Moreira; Javier P Gisbert; Fernando González-Palacios; J L García López
[Pancreatic vipoma with bizarre characteristics].
Gastroenterología y hepatología 1999;22(3):132-5.
1999: Javier P Gisbert; Daniel Boixeda; R Aller; C de la Serna; E Sanz; Carlos Martín de Argila; Víctor Abraira; Antonio García Plaza
[Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
Medicina clínica 1999;112(5):161-5.
1999: Javier P Gisbert
[Lansoprazole: a review of its role in Helicobacter pylori eradication therapy].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1999;91(2):133-43.
1999: F Bermejo; Víctor Moreira; Carolina Redondo; MA Martín Scapa; Javier P Gisbert; Víctor Defarges; R Aller
Collagenous colitis in Spain: a report of nine new cases.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1999;91(2):93-104.
1999: Javier P Gisbert; Daniel Boixeda; A Al-Mostafa; T Vila; Luis de Rafael; I Alvarez Baleriola; Carlos Martín de Argila; Víctor Abraira
Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
European journal of gastroenterology & hepatology 1999;11(2):189-200.
1999: M I García-Arata; Fernando Baquero; Luis de Rafael; Carlos Martín de Argila; Javier P Gisbert; F Bermejo; Daniel Boixeda; R Cantón
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin.
Antimicrobial agents and chemotherapy 1999;43(2):374-6.
1998: Javier P Gisbert
[The attitude in a failure to eradicate Helicobacter pylori: surrender or fight?].
Medicina clínica 1998;111(20):778-82.
1998: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila
[Previous treatment with omeprazole and H. pylori: does it diminish the eradication efficacy of the "new" triple therapies of one week's duration?].
Medicina clínica 1998;111(18):716.
1998: Javier P Gisbert; José María Pajares; R García-Valriberas; Víctor Abraira; Daniel Boixeda; Rafael García-Grávalos; Carlos Martín de Argila; Antonio García Plaza
Recurrence of Helicobacter pylori infection after eradication: incidence and variables influencing it.
Scandinavian journal of gastroenterology 1998;33(11):1144-51.
1998: Javier P Gisbert
[Reinfection by Helicobacter pylori after its eradication: irrational fear?].
Medicina clínica 1998;111(10):380-4.
1998: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila; Antonio García Plaza
[Role of pantoprazole in the eradicating treatment of Helicobacter pylori].
Revista clínica española 1998;198(10):678-83.
1998: Javier P Gisbert; Daniel Boixeda; F Bermejo; L Moreno; F Ramos; Carlos Martín de Argila; I García-Arata; Antonio García Plaza
[Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?].
Revista clínica española 1998;198(10):655-9.
1998: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila; Antonio García Plaza
[Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1998;90(9):655-64.
1998: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila; Antonio García Plaza
[Helicobacter pylori and non-ulcer dyspepsia: a pending matter].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1998;90(6):441-53.
1998: Carlos Martín de Argila; Daniel Boixeda; S Valdezate; N Mir; R Bárcena; Javier P Gisbert; Antonio García Plaza; R Cantón
ABO blood groups, rhesus factor and Helicobacter pylori.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1998;90(4):263-8.
1998: Javier P Gisbert
[Is gastric lymphoma an infectious disease?].
Medicina clínica 1998;110(2):56-61.
1998: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila; Carolina Redondo; L Moreno; Víctor Abraira; Antonio García Plaza
[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Medicina clínica 1998;110(1):1-5.
1998: Javier P Gisbert; J M Pajares
[Are there "good" H. pylori and "bad" H. pylori?/].
Acta gastroenterologica Latinoamericana 1998;28(5):341-8.
1997: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila
[Infection by Helicobacter pylori: where is the limit?].
Medicina clínica 1997;109(20):808-17.
1997: Carlos Martín de Argila; Daniel Boixeda; R Cantón; S Valdezate; N Mir; Luis de Rafael; Javier P Gisbert; Fernando Baquero
Usefulness of the combined IgG and IgA antibody determinations for serodiagnosis of Helicobacter pylori infection.
European journal of gastroenterology & hepatology 1997;9(12):1191-6.
1997: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila; Antonio García Plaza
[Helicobacter pylori and duodenal ulcer: a causal relation or mere association?].
Revista clínica española 1997;197(10):693-702.
1997: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila; F Bermejo; Carolina Redondo; Luis de Rafael
Erosive duodenitis: prevalence of Helicobacter pylori infection and response to eradication therapy with omeprazole plus two antibiotics.
European journal of gastroenterology & hepatology 1997;9(10):957-62.
1997: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila; I Alvarez Baleriola; Víctor Abraira; Antonio García Plaza
Unhealed duodenal ulcers despite Helicobacter pylori eradication.
Scandinavian journal of gastroenterology 1997;32(7):643-50.
1997: Javier P Gisbert; M Mur; Daniel Boixeda; G Ceña; Carlos Martín de Argila; I Alvarez Baleriola; Víctor Abraira; Antonio García Plaza
[One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer].
Medicina clínica 1997;108(14):524-9.
1997: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila
[What is the current role of clarithromycin in the eradication of Helicobacter pylori?].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1997;89(4):305-12.
1997: Carlos Martín de Argila; Daniel Boixeda; Carolina Redondo; I Alvarez; Javier P Gisbert; Antonio García Plaza; R Cantón
Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori.
Scandinavian journal of gastroenterology 1997;32(4):303-7.
1997: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila
[What is the current therapeutic role of omeprazole in gastroduodenal ulcer disease?].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1997;89(2):116-23.
1996: Carlos Martín de Argila; Daniel Boixeda; R Cantón; N Mir; Luis de Rafael; Javier P Gisbert; C Arocena; Antonio García Plaza
Helicobacter pylori infection in a healthy population in Spain.
European journal of gastroenterology & hepatology 1996;8(12):1165-8.
1996: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila; Antonio García Plaza
[Why, when and how to treat Helicobacter pylori infection in gastroduodenal ulcer disease?].
Revista clínica española 1996;196(9):610-21.
1996: Javier P Gisbert; Daniel Boixeda; I Alvarez Baleriola; Carlos Martín de Argila; F Bermejo; R Aller
[Erradicating treatment of Helicobacter pylori with lansoprazole and amoxicillin in duodenal ulcer patients].
Revista clínica española 1996;196(9):588-93.
1996: Javier P Gisbert; Daniel Boixeda; Carlos Martín de Argila
[Is gastric cancer an infectious disease?].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1996;88(8):555-62.
1996: Javier P Gisbert; D Boixeda; Carlos Martín de Argila; F Bermejo; T Pérez; I Jiménez
[Is there a correlation between the values of breath tests and the response to the treatment for the eradication of Helicobacter pylori?].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1996;88(7):465-9.
1996: Daniel Boixeda; Javier P Gisbert; C Arocena; Rafael Cantón; I Alvarez Baleriola; Carlos Martín de Argila; Antonio García Plaza
[Prevalence of Helicobacter pylori infection in gastric adenocarcinoma and chronic gastritis].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1996;88(6):403-8.
1996: Víctor Moreira; C Arocena; Carolina Redondo; F Hernández-Ranz; Javier P Gisbert
[Adenoma of Vater's ampulla without clinical or analytical expression].
Revista clínica española 1996;196(5):343-4.
1996: Javier P Gisbert; Daniel Boixeda; Luis de Rafael; Carolina Redondo; Carlos Martín de Argila; F Bermejo
[Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1996;88(5):317-22.
1996: Javier P Gisbert; Daniel Boixeda; Carolina Redondo; I Alvarez Baleriola; I Jiménez; J I Pérez García; José María Pajares
[Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1996;88(4):259-64.
1996: Javier P Gisbert; Daniel Boixeda; T Vila; Rafael Cantón; I Alvarez Baleriola; V Defarges; Carlos Martín de Argila
[Helicobacter pylori infection and basal levels of serum gastrins in patients with duodenal ulcer and subjects with normal endoscopy].
Medicina clínica 1996;106(9):325-8.
1996: Javier P Gisbert; Daniel Boixeda; T Vila; Luis de Rafael; Carolina Redondo; Carlos Martín de Argila
Basal and stimulated gastrin levels and gastric acid output five months after therapy for Helicobacter pylori eradication in duodenal ulcer patients.
Journal of clinical gastroenterology 1996;22(2):90-5.
1996: Javier P Gisbert; Daniel Boixeda; Luis de Rafael; I Alvarez Baleriola; Carlos Martín de Argila; M García; Antonio García Plaza
[What factors influence healing of duodenal ulcer when Helicobacter pylori eradication treatment is used?].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1996;88(3):179-84.
1996: Daniel Boixeda; Javier P Gisbert; Rafael Cantón; I Alvarez Baleriola; F Bermejo; R Aller; Carlos Martín de Argila
[Helicobacter pylori, gastric ulcer and non-steroidal anti-inflammatory agents].
Medicina clínica 1996;106(6):209-12.
1996: Javier P Gisbert; M Mur; S Sainz; G Ceña; C Martín; R Sainz; Daniel Boixeda; Joan Monés
[Is the omeprazole and amoxicillin combination useful in the treatment eradicating Helicobacter pylori in Spain?].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1996;88(2):99-106.
1996: Javier P Gisbert; Daniel Boixeda; T Vila; Luis de Rafael; Carolina Redondo; Rafael Cantón; Carlos Martín de Argila
Verification of decreased basal and stimulated serum pepsinogen-I levels is a useful non-invasive method for determining the success of eradication therapy for Helicobacter pylori.
Scandinavian journal of gastroenterology 1996;31(2):103-10.
1996: Javier P Gisbert; Daniel Boixeda; T Vila; Luis de Rafael; Carolina Redondo; Carlos Martín de Argila; C Arocena
[Basal levels of blood pepsinogen I and Helicobacter pylori infection in patients with duodenal ulcer and normal endoscopy].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1996;88(1):3-8.
1996: Javier P Gisbert; Daniel Boixeda; C Martín de Argila; M Mur Villacampa; Joan Monés; R Sáinz Samitier
Response to article by Forné et al.
The American journal of gastroenterology 1996;91(1):176-7.
1995: Daniel Boixeda; Javier P Gisbert; Rafael Cantón; I Alvarez Baleriola; L A Gil Grande; Carlos Martín de Argila
[Is there any association between Helicobacter pylori infection and peptic esophagitis?].
Medicina clínica 1995;105(20):774-7.
1995: Javier P Gisbert; Daniel Boixeda; I Alvarez Baleriola; A Manzanal
[A favorable clinical, endoscopic and histological response after Helicobacter pylori eradication in a patient with a suspected gastric lymphoma].
Revista clínica española 1995;195(12):886-7.
1995: Javier P Gisbert; Daniel Boixeda; F Hernández Ranz; Carlos Martín de Argila
[Eradication of Helicobacter pylori and hemorrhagic recurrence of duodenal ulcer].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1995;87(12):910-1.
1995: Daniel Boixeda; Javier P Gisbert; Luis de Rafael; I Alvarez Baleriola; Carlos Martín de Argila; F Bermejo; Antonio García Plaza
[The importance of obtaining biopsies of the gastric body in the follow-up after eradicating treatment of Helicobacter pylori].
Medicina clínica 1995;105(15):566-9.
1995: Javier P Gisbert; Daniel Boixeda; T Vila; Luis de Rafael; I Alvarez Baleriola; Carlos Martín de Argila
[Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?].
Medicina clínica 1995;105(15):561-5.
1995: Javier P Gisbert; Daniel Boixeda; C Martin de Argila
[Omeprazole and amoxycillin in the eradicating treatment of Helicobacter pylori].
Revista clínica española 1995;195(11):787-91.
1995: Daniel Boixeda; Javier P Gisbert; Luis de Rafael; Carolina Redondo; AL San Román; Carlos Martín de Argila; A Cano
[Prevalence of Helicobacter pylori infection in gastrectomy and vagotomy].
Revista clínica española 1995;195(11):757-60.
1995: Javier P Gisbert; MA Martín Scapa; I Alvarez Baleriola; Víctor Moreira Vicente; F Hernández Ranz
[Diarrhea, a constitutional syndrome and arthralgias].
Revista clínica española 1995;195(9):657-8.
1995: Javier P Gisbert; MA Martín Scapa; I Alvarez Baleriola; Víctor Moreira Vicente; F H Hernández Ranz
[Whipple's disease: an entity to keep in mind].
Revista clínica española 1995;195(9):627-32.
1995: C Martîn-de-Argila; D Boixeda; R Cantón; Javier P Gisbert; A Fuertes
High seroprevalence of Helicobacter pylori infection in coronary heart disease.
Lancet 1995;346(8970):310.
1995: Javier P Gisbert; Daniel Boixeda; T Vila; Carlos Martín de Argila; F Bermejo; A al-Mostafa; C de la Serna
[A global study of gastric secretion in duodenal ulcers: gastrin, pepsinogen and acid secretion].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1995;87(7):491-7.
1995: Javier P Gisbert; Daniel Boixeda; I Alvarez Baleriola; Carolina Redondo; Luis de Rafael; Carlos Martín de Argila; F Hernández Ranz
[Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1995;87(4):281-7.
1995: Daniel Boixeda de Miquel; Javier P Gisbert; Carlos Martín de Argila
[The physiopathology of duodenal ulcer: an attempt at a link between "classical" knowledge and Helicobacter pylori infection].
Revista clínica española 1995;195(4):246-55.
1995: Daniel Boixeda; Javier P Gisbert; Carlos Martín de Argila; Rafael Cantón; A al-Mustafa
[H. pylori infection at the duodenal bulb in different endoscopic diagnoses].
Revista clínica española 1995;195(4):220-5.
1995: Daniel Boixeda; Javier P Gisbert; T Vila; Rafael Cantón; Carolina Redondo; Carlos Martín de Argila; A Cano; Antonio García Plaza
[A decrease in the basal levels of serum pepsinogen I after H. pylori eradication].
Revista clínica española 1995;195(4):214-9.
1995: Javier P Gisbert; Daniel Boixeda; Luis de Rafael; Carlos Martín de Argila; F Bermejo; Antonio García Plaza
[The effect of "triple therapy" on the eradicating of H. pylori and the healing of a duodenal ulcer. The initial study and 6 months later].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1995;87(3):193-8.
1995: Carlos Martín de Argila; V Moreira; Javier P Gisbert
[Gastrointestinal lesions produced by nonsteroidal anti-inflammatory agents: the clinical manifestations, risk factors, physiopathology, prevention and treatment].
Anales de medicina interna (Madrid, Spain : 1984) 1995;12(2):85-96.
1995: Javier P Gisbert; Daniel Boixeda; T Vila; Luis de Rafael; I Alvarez Baleriola; Víctor Moreira; Carlos Martín de Argila; C Arocena; Antonio García Plaza
[Decrease of basal levels of gastrin following H. pylori eradication].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1995;87(2):99-107.
1995: Daniel Boixeda; Javier P Gisbert; Carlos Martín de Argila; Rafael Cantón; F Bermejo; Antonio García Plaza
[Is there a relationship between digestive symptoms and H. pylori infection?].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1995;87(1):8-14.
1994: Daniel Boixeda; Carlos Martín de Argila; Rafael Cantón; I Alvarez Baleriola; Javier P Gisbert; Rafael Barcena; V Defarges; M Serrano Ríos
[Prevalence of Helicobacter pylori infection in symptomatic adults].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1994;86(2):569-76.
1992: M García; AL Sanromán; Javier P Gisbert; C Martín de Argila; Víctor Moreira
Aeromonas sobria spontaneous bacterial peritonitis.
The American journal of gastroenterology 1992;87(12):1890-1.
1991: Víctor Moreira; AL San Román; E Meroño; R Arribas; M García; Javier P Gisbert
[Endoscopic choledochoduodenostomy in the treatment of impacted calculi in Vater's papilla].
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1991;80(5):320-3.